CA2284752A1 - Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested - Google Patents
Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested Download PDFInfo
- Publication number
- CA2284752A1 CA2284752A1 CA002284752A CA2284752A CA2284752A1 CA 2284752 A1 CA2284752 A1 CA 2284752A1 CA 002284752 A CA002284752 A CA 002284752A CA 2284752 A CA2284752 A CA 2284752A CA 2284752 A1 CA2284752 A1 CA 2284752A1
- Authority
- CA
- Canada
- Prior art keywords
- lumen
- patient
- arterial cannula
- aortic occlusion
- catheter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 C=**C1CCCC1 Chemical compound C=**C1CCCC1 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/02—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors
- A61B17/0206—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors with antagonistic arms as supports for retractor elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
- A61B17/3421—Cannulas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1084—Balloon catheters with special features or adapted for special applications having features for increasing the shape stability, the reproducibility or for limiting expansion, e.g. containments, wrapped around fibres, yarns or strands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/12—Blood circulatory system
- A61M2210/127—Aorta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1002—Balloon catheters characterised by balloon shape
Abstract
A method and device for occluding a patient's ascending aorta, maintaining circulation of oxygenated blood in the patient and delivering cardioplegic fluid to arrest the patient's heart. An aortic occlusion catheter has an occluding member for occluding the ascending aorta. The aortic occlusion catheter passes through a cannula. Delivery of oxygenated blood is accomplished through either the cannula or the aortic occlusion catheter. In another aspect of the invention, an arterial cannula having a curved or angled distal portion. An introducer straightens the distal portion for introduction into the patient. In still another aspect of the invention, an open-mesh stabilizer is used to stabilize a discoid occluding member.
Description
2 PCT/US99/01340 METHODS AND DEVICES FOR OCCLUIDING THE ASCENDING AORTA
AND MAINTAINING CIRCULATION OF OXYGENATED BLOOD IN THE
PATIENT WHEN THE PATIENT"S HEART IS ARRESTED
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a continuation-in-part of U.S. Patent Application No.
09/012,833, filed January 23, 1998, which is incorporated herein by reference.
BACKGROUND OF TH:E INVENTION
The present invention is directed to methods and devices for occluding a patient's ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested. Such devices and methods are useful for performing various procedures on a patient's vascular system and heart such as the procedures described in U.S. Patent Nos. 5,584,803 and 5,682,906 which describe coronary artery bypass grafting (CABG) and valve procedures, respectively.
Another device and method for occluding a patient's ascending aorta is described in Re.
35,352.
2o The methods and devices described in the above-mentioned patents use an internal occlusion device to occlude the ascending aorta rather than a conventional external cross-clamp. Use of an internal occlusion device may reduce strokes as compared to conventional external cross-clamps since external cross-clamps distort and compress the aorta which may release emboli leading to strokes.
It is an object of the invention to provide alternative methods and devices for occluding a patient's ascending aorta and maintaining circulation of oxygenated blood when the patient's heart is arrested.
SUMMARY OF THE INVENTION
3o In accordance with the object of the invention, the present invention provides alternative methods and devices for occluding a patient's ascending aorta and maintaining circulation of oxygenated blood in a patient when the patient's heart is arrested.
In a first preferred method and device ot- the present invention. an aortic occlusion device having a blood delivery lumen and an occluding member is introduced into the patient's aortic arch. The occluding member has an interior in fluid communication with the blood delivery lumen so that delivery of oxygenated blood inflates the occluding member. An advantage of this method is that a separate inflation lumen is not necessary. The aortic occlusion device preferably passes through a cannula having a y-arm with the aortic occlusion catheter passing through an arm of the y-ann. The other arm of the y-ann connector is coupled to the source of oxygenated blood so that bypass support can be: maintained even when the aortic occlusion device has been removed.
In another preferred method and device.. oxygenated blood is delivered to the patient through the aortic occlusion catheter. The aortic occlusion catheter also passes through a cannula with a y-arm connector so that bypass support can be maintained when the aortic occlusion device is removed. 'l.'he aortic occlusion device also preferably includes a lumen for delivering cardioplegic fluid and venting the ascending aorta and a pressure lumen for measuring pressure in the ascending aorta.
If the lumens are not provided in the aortic occlusion device, delivery of cardioplegic fluid, venting of the ascending aorta and pressure monitoring may be accomplished with the cannula.
In another preferred device, the aortic occlusion device has an occluding member mounted to a side of the catheter. The. occluding member has a pathway therethrough which is in communication with a lumen in the aortic occlusion catheter.
The pathway directs cardioplegic fluid toward the coronary ostia while the aortic occlusion device directs the oxygenated blood in the direction of normal blood flow in the aorta.
In another aspect of the invention, the c:annula has a curved or angled distal end. The distal end is straightened for introduction by the introducer.
In still another aspect of the present invention, the occluding member is stabilized by a mesh structure to prevent distortion of the occluding member.
These and other aspects and advantages of the present invention will become apparent from the following description and drawings.
AND MAINTAINING CIRCULATION OF OXYGENATED BLOOD IN THE
PATIENT WHEN THE PATIENT"S HEART IS ARRESTED
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a continuation-in-part of U.S. Patent Application No.
09/012,833, filed January 23, 1998, which is incorporated herein by reference.
BACKGROUND OF TH:E INVENTION
The present invention is directed to methods and devices for occluding a patient's ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested. Such devices and methods are useful for performing various procedures on a patient's vascular system and heart such as the procedures described in U.S. Patent Nos. 5,584,803 and 5,682,906 which describe coronary artery bypass grafting (CABG) and valve procedures, respectively.
Another device and method for occluding a patient's ascending aorta is described in Re.
35,352.
2o The methods and devices described in the above-mentioned patents use an internal occlusion device to occlude the ascending aorta rather than a conventional external cross-clamp. Use of an internal occlusion device may reduce strokes as compared to conventional external cross-clamps since external cross-clamps distort and compress the aorta which may release emboli leading to strokes.
It is an object of the invention to provide alternative methods and devices for occluding a patient's ascending aorta and maintaining circulation of oxygenated blood when the patient's heart is arrested.
SUMMARY OF THE INVENTION
3o In accordance with the object of the invention, the present invention provides alternative methods and devices for occluding a patient's ascending aorta and maintaining circulation of oxygenated blood in a patient when the patient's heart is arrested.
In a first preferred method and device ot- the present invention. an aortic occlusion device having a blood delivery lumen and an occluding member is introduced into the patient's aortic arch. The occluding member has an interior in fluid communication with the blood delivery lumen so that delivery of oxygenated blood inflates the occluding member. An advantage of this method is that a separate inflation lumen is not necessary. The aortic occlusion device preferably passes through a cannula having a y-arm with the aortic occlusion catheter passing through an arm of the y-ann. The other arm of the y-ann connector is coupled to the source of oxygenated blood so that bypass support can be: maintained even when the aortic occlusion device has been removed.
In another preferred method and device.. oxygenated blood is delivered to the patient through the aortic occlusion catheter. The aortic occlusion catheter also passes through a cannula with a y-arm connector so that bypass support can be maintained when the aortic occlusion device is removed. 'l.'he aortic occlusion device also preferably includes a lumen for delivering cardioplegic fluid and venting the ascending aorta and a pressure lumen for measuring pressure in the ascending aorta.
If the lumens are not provided in the aortic occlusion device, delivery of cardioplegic fluid, venting of the ascending aorta and pressure monitoring may be accomplished with the cannula.
In another preferred device, the aortic occlusion device has an occluding member mounted to a side of the catheter. The. occluding member has a pathway therethrough which is in communication with a lumen in the aortic occlusion catheter.
The pathway directs cardioplegic fluid toward the coronary ostia while the aortic occlusion device directs the oxygenated blood in the direction of normal blood flow in the aorta.
In another aspect of the invention, the c:annula has a curved or angled distal end. The distal end is straightened for introduction by the introducer.
In still another aspect of the present invention, the occluding member is stabilized by a mesh structure to prevent distortion of the occluding member.
These and other aspects and advantages of the present invention will become apparent from the following description and drawings.
3 PCT/US99/01340 BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 shows an aortic occlusion device:
Fig. 2 is a cross-sectional view of a first step in forming the aortic occlusion catheter of Fig. 1;
Fig. 3 is a cross-sectional view of the sUructure of Fig. 2 after heating;
Fig. 4 is a cross-sectional view of a further step in forming the aortic occlusion catheter of Fig. 1;
Fig. 5 is a cross-sectional view of Fig. 1 along line I-I;
Fig. 6 shows a cannula;
t0 Fig. 7 shows an enlarged view of the distal end of the cannula of Fig. 6;
Fig. 8 is a plan view of a ring;
Fig. 9 is a side view of the ring;
Fig. 10 shows an introduces with an incising element in a retracted position;
Fig. 11 shows the introduces with the incising element in an exposed position;
Fig. 12 shows the aortic occlusion device and cannula passing through a penetration in the ascending aorta;
Fig. 13 shows another aortic occlusion device passing through the cannula and into the patient's ascending aorta;
Fig. 14 shows yet another aortic occlusion device;
2o Fig. 15 shows still another aortic occlusion device;
Fig. 16 shows a final aortic occlusion device:
Fig. 17 illustrates a preferred method of introducing the aortic occlusion device;
Fig. 18 shows another preferred aortic occlusion device with the balloon occluding the ascending aorta; and Fig. 19 shows the aortic occlusion device of Fig. l 8 with the balloon deflated.
Fig. 20 shows a cannula having an anglaed or curved distal portion;
Fig. 21 shows the distal portion of the c;annula of Fig. 20;
Fig. 22 shows the cannula of Fig. 20 with the introduces straightening the 3o distal portion;
Fig. 23 illustrates introduction of the cannula;
Fig. 24 shows the aortic occlusion device passed through the cannula;
Fig. 1 shows an aortic occlusion device:
Fig. 2 is a cross-sectional view of a first step in forming the aortic occlusion catheter of Fig. 1;
Fig. 3 is a cross-sectional view of the sUructure of Fig. 2 after heating;
Fig. 4 is a cross-sectional view of a further step in forming the aortic occlusion catheter of Fig. 1;
Fig. 5 is a cross-sectional view of Fig. 1 along line I-I;
Fig. 6 shows a cannula;
t0 Fig. 7 shows an enlarged view of the distal end of the cannula of Fig. 6;
Fig. 8 is a plan view of a ring;
Fig. 9 is a side view of the ring;
Fig. 10 shows an introduces with an incising element in a retracted position;
Fig. 11 shows the introduces with the incising element in an exposed position;
Fig. 12 shows the aortic occlusion device and cannula passing through a penetration in the ascending aorta;
Fig. 13 shows another aortic occlusion device passing through the cannula and into the patient's ascending aorta;
Fig. 14 shows yet another aortic occlusion device;
2o Fig. 15 shows still another aortic occlusion device;
Fig. 16 shows a final aortic occlusion device:
Fig. 17 illustrates a preferred method of introducing the aortic occlusion device;
Fig. 18 shows another preferred aortic occlusion device with the balloon occluding the ascending aorta; and Fig. 19 shows the aortic occlusion device of Fig. l 8 with the balloon deflated.
Fig. 20 shows a cannula having an anglaed or curved distal portion;
Fig. 21 shows the distal portion of the c;annula of Fig. 20;
Fig. 22 shows the cannula of Fig. 20 with the introduces straightening the 3o distal portion;
Fig. 23 illustrates introduction of the cannula;
Fig. 24 shows the aortic occlusion device passed through the cannula;
4 Fia. ?~ shows the cannula of Fia. 20 including an occluding member:
Fig. 26 shows another cannula having a angled shaft and an angled stabilizing nng;
Fig. 27 shows the cannula of Fig. 26 with the introduces straightening the s shaft;
Fig. 28 shows a balloon having a first, snnaller section stabilized by a second.
larger section:
Fig. 29 is an end view of the balloon along line II-II of Fig. 28;
Fig. 30 is a cross-sectional view of Fig. 28 along line III-III;
to Fig. 31 shows the balloon of Fig. 28 having a different orientation on the shaft;
Fig. 32 shows yet another orientation for the balloon of Fig. 28;
Fig. 33 shows a discoid occluding member supported by a stabilizer having an open structure which permits blood flow to the head and neck vessels;
Fig. 34 shows the stabilizer of Fig. 33 in a collapsed position; and 15 Fig. 35 shows the stabilizer of Fig. 33 in an expanded position.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
Referring to Figs. 1 and 5, an aortic occhusion device 2 is shown. The aortic occlusion device 2 has an occluding member 4 configured to occlude a patient's 2o ascending aorta. The occluding member 4 is preferably a balloon but may also be a mechanically actuated member. The aortic occlusion device 2 has an inflation lumen 6 for inflating the occluding member 4, a pressure lumen 8 for measuring pressure in the ascending aorta, and a lumen l0 for delivering cardioplegic fluid and/or venting the ascending aorta. The aortic occlusion devicE: 2 is preferably manufactured and 25 used in the manner described in U.S. Patent Application Serial No. 08/782,1 I 3 but may also be manufactured in any other manner such as an extrusion.
The aortic occlusion device 2 is preferably substantially straight in an unbiased position, however, the aortic occlusion device 2 may also have a shaped end.
For example, the aortic occlusion catheter 2 can have an L-shaped end which facilitates 3o positioning the occluding member 4 in the ascending aorta depending upon the surgical approach. The aortic occlusion device 2 is preferably flexible so that it can be bent as necessary without kinking.
*rB
Referring to Figs. 2-5. a preferred method of forming the aortic occlusion device ? is shown. Fig. 2 shows a longitudinal cross-section of a tube 1 ~, preferably a urethane tube, mounted on a teflon-coated mandrel 14 with the eloneate element wound helically around the tube 12. The elongate element 16 is preferably a wire
Fig. 26 shows another cannula having a angled shaft and an angled stabilizing nng;
Fig. 27 shows the cannula of Fig. 26 with the introduces straightening the s shaft;
Fig. 28 shows a balloon having a first, snnaller section stabilized by a second.
larger section:
Fig. 29 is an end view of the balloon along line II-II of Fig. 28;
Fig. 30 is a cross-sectional view of Fig. 28 along line III-III;
to Fig. 31 shows the balloon of Fig. 28 having a different orientation on the shaft;
Fig. 32 shows yet another orientation for the balloon of Fig. 28;
Fig. 33 shows a discoid occluding member supported by a stabilizer having an open structure which permits blood flow to the head and neck vessels;
Fig. 34 shows the stabilizer of Fig. 33 in a collapsed position; and 15 Fig. 35 shows the stabilizer of Fig. 33 in an expanded position.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
Referring to Figs. 1 and 5, an aortic occhusion device 2 is shown. The aortic occlusion device 2 has an occluding member 4 configured to occlude a patient's 2o ascending aorta. The occluding member 4 is preferably a balloon but may also be a mechanically actuated member. The aortic occlusion device 2 has an inflation lumen 6 for inflating the occluding member 4, a pressure lumen 8 for measuring pressure in the ascending aorta, and a lumen l0 for delivering cardioplegic fluid and/or venting the ascending aorta. The aortic occlusion devicE: 2 is preferably manufactured and 25 used in the manner described in U.S. Patent Application Serial No. 08/782,1 I 3 but may also be manufactured in any other manner such as an extrusion.
The aortic occlusion device 2 is preferably substantially straight in an unbiased position, however, the aortic occlusion device 2 may also have a shaped end.
For example, the aortic occlusion catheter 2 can have an L-shaped end which facilitates 3o positioning the occluding member 4 in the ascending aorta depending upon the surgical approach. The aortic occlusion device 2 is preferably flexible so that it can be bent as necessary without kinking.
*rB
Referring to Figs. 2-5. a preferred method of forming the aortic occlusion device ? is shown. Fig. 2 shows a longitudinal cross-section of a tube 1 ~, preferably a urethane tube, mounted on a teflon-coated mandrel 14 with the eloneate element wound helically around the tube 12. The elongate element 16 is preferably a wire
5 ribbon having a thickness of 0.003 inch and a width of 0.012 inch. The elongate element 16 is preferably wrapped around the tube 12 with a spacing of 0.010 inch.
Another tube 20 is positioned over the elongate member 16 and a shrink tube (not shown) is positioned over the tube 20. The entire structure is then heated to fuse the tubes together to form a reinforced tube 22 which is shown in longitudinal cross-section in Fig. 3. The resulting reinforced tube 22 preferably has an inner diameter of about 0.100 inch and a wall thickness of about 0.010 inch.
Referring to Fig. 4, a two-lumen member 24 is positioned against the reinforced tube 22 and a shrink tube 26 is positioned around the member 24 and reinforced tube 22. The two-lumen member 24 has the inflation lumen 6, which is used for inflating the occluding member 4, and the pressure lumen 8, which is used for pressure monitoring in the ascending aorta. Thf: two-lumen member 24 is preferably an extrusion having a D-shaped outer surface in cross-section. The member 24 and tube 22 are then heated and the shrink tube 26 i;~ removed to obtain the egg-shaped cross-sectional shape shown in Fig. 5. The cross-sectional shape is preferably about 0.145 inch tall and 0.125 inch wide. The inflation lumen 6 is then pierced to provide an inflation path to the occluding member 4 and the occluding member 4 is then mounted to the shaft.
Referring to Figs. 6 and 7, a cannula 28 is shown which is used to return oxygenated blood to the patient when the patient's heart is arrested. The aortic occlusion device 2 is introduced into the patiem; through the cannula 28 as will be described below. The cannula 28 has a y-arm connector 30 with first and second arms 32, 34 with each coupled to a lumen 35. The second arm 34 has a hemostasis valve 36 which may be any hemostasis valve and is preferably a Thouy-Borst valve.
The cannula 28 has a reinforced body 38 which is preferably formed in the manner 3o described in U.S. Patent Application No. 08/74!x,683, which is hereby incorporated by reference, however, any other method may be used including extrusion. The distal end 40 of the cannula 28 is beveled and has an .open end 42 and two side ports 44 for
Another tube 20 is positioned over the elongate member 16 and a shrink tube (not shown) is positioned over the tube 20. The entire structure is then heated to fuse the tubes together to form a reinforced tube 22 which is shown in longitudinal cross-section in Fig. 3. The resulting reinforced tube 22 preferably has an inner diameter of about 0.100 inch and a wall thickness of about 0.010 inch.
Referring to Fig. 4, a two-lumen member 24 is positioned against the reinforced tube 22 and a shrink tube 26 is positioned around the member 24 and reinforced tube 22. The two-lumen member 24 has the inflation lumen 6, which is used for inflating the occluding member 4, and the pressure lumen 8, which is used for pressure monitoring in the ascending aorta. Thf: two-lumen member 24 is preferably an extrusion having a D-shaped outer surface in cross-section. The member 24 and tube 22 are then heated and the shrink tube 26 i;~ removed to obtain the egg-shaped cross-sectional shape shown in Fig. 5. The cross-sectional shape is preferably about 0.145 inch tall and 0.125 inch wide. The inflation lumen 6 is then pierced to provide an inflation path to the occluding member 4 and the occluding member 4 is then mounted to the shaft.
Referring to Figs. 6 and 7, a cannula 28 is shown which is used to return oxygenated blood to the patient when the patient's heart is arrested. The aortic occlusion device 2 is introduced into the patiem; through the cannula 28 as will be described below. The cannula 28 has a y-arm connector 30 with first and second arms 32, 34 with each coupled to a lumen 35. The second arm 34 has a hemostasis valve 36 which may be any hemostasis valve and is preferably a Thouy-Borst valve.
The cannula 28 has a reinforced body 38 which is preferably formed in the manner 3o described in U.S. Patent Application No. 08/74!x,683, which is hereby incorporated by reference, however, any other method may be used including extrusion. The distal end 40 of the cannula 28 is beveled and has an .open end 42 and two side ports 44 for
6 PCT/US99/01340 infusing oxygenated blood into the patient. r1 radiopaque markers =4~ are provided at the distal end for visualization as discussed below.
Referring to Firs. 6-9. a ring 46 is attached to the distal end 40 of the cannula 28. The ring 46 limits insertion of the cannula 28 into the vessel. stabilizes the cannula 28, and receives purse-string sutures which provide hemostasis around the cannula 28 when the cannula 28 is positioned in a vessel. Referring to Figs. 8 and 9, the ring 46 has slots 48 which may receive purse-string sutures as will be described below.
Referring to Figs. 10 and 11, an introduc;er 50 is positioned in the cannula to introduce the cannula 28 into a vessel. The introduces 50 has a connector hub 51 which is received by the hemostasis valve 36 on the second arm 32 of the cannula 28 to seal the space between the introduces 50 and cannula 28. The introduces 50 has an incising element 52 for incising the vessel into which the cannula 28 is introduced.
The incising element 52 is attached to a shaft 54~ which is coupled to a trigger 56 for t5 moving the incising element 52 from the retracted position of Fig. 10 to the exposed position of Fig. 11. An o-ring seals 58 the space between an outer housing 60 and the shaft 54. The incising element 52 is biased toward the retracted position by a spring 62 so that the incising element 52 is only exposed when the trigger 56 is actuated.
When introducing the cannula 28 into the vessel, the trigger 56 is actuated to move the 2o incising element 52 to the exposed position, the vessel is incised with the incising element 52 and the cannula 28 is inserted throul;h the incision. As will be described below, one or more purse-string sutures are then used to form a hemostatic seal around the cannula 28. The incising element 52 may be omitted if a separate incising device is used.
25 Referring to Figs. 12, the cannula 28 is positioned in a patient's ascending aorta with the aortic occlusion device 2 passing through the hemostasis valve 36 .
Placement of the cannula 28 and aortic occlusion device 2 into the position of Fig. 12 is described below. Referring to Figs. 5 and 12, the lumen 10 is coupled to a source of cardioplegic fluid 64, the inflation lumen 6 is coupled to a source of inflation fluid 66, 30 and the pressure lumen 8 is coupled to the pressure monitor 68 for measuring pressure in the ascending aorta. The lumen 10 is also coupled to a vacuum source 70 for venting the ascending aorta.
*rB
Referring to Firs. 6-9. a ring 46 is attached to the distal end 40 of the cannula 28. The ring 46 limits insertion of the cannula 28 into the vessel. stabilizes the cannula 28, and receives purse-string sutures which provide hemostasis around the cannula 28 when the cannula 28 is positioned in a vessel. Referring to Figs. 8 and 9, the ring 46 has slots 48 which may receive purse-string sutures as will be described below.
Referring to Figs. 10 and 11, an introduc;er 50 is positioned in the cannula to introduce the cannula 28 into a vessel. The introduces 50 has a connector hub 51 which is received by the hemostasis valve 36 on the second arm 32 of the cannula 28 to seal the space between the introduces 50 and cannula 28. The introduces 50 has an incising element 52 for incising the vessel into which the cannula 28 is introduced.
The incising element 52 is attached to a shaft 54~ which is coupled to a trigger 56 for t5 moving the incising element 52 from the retracted position of Fig. 10 to the exposed position of Fig. 11. An o-ring seals 58 the space between an outer housing 60 and the shaft 54. The incising element 52 is biased toward the retracted position by a spring 62 so that the incising element 52 is only exposed when the trigger 56 is actuated.
When introducing the cannula 28 into the vessel, the trigger 56 is actuated to move the 2o incising element 52 to the exposed position, the vessel is incised with the incising element 52 and the cannula 28 is inserted throul;h the incision. As will be described below, one or more purse-string sutures are then used to form a hemostatic seal around the cannula 28. The incising element 52 may be omitted if a separate incising device is used.
25 Referring to Figs. 12, the cannula 28 is positioned in a patient's ascending aorta with the aortic occlusion device 2 passing through the hemostasis valve 36 .
Placement of the cannula 28 and aortic occlusion device 2 into the position of Fig. 12 is described below. Referring to Figs. 5 and 12, the lumen 10 is coupled to a source of cardioplegic fluid 64, the inflation lumen 6 is coupled to a source of inflation fluid 66, 30 and the pressure lumen 8 is coupled to the pressure monitor 68 for measuring pressure in the ascending aorta. The lumen 10 is also coupled to a vacuum source 70 for venting the ascending aorta.
*rB
7 The first arm 32 of the cannula 28 is coupled to a source of oxygenated blood 72 so that blood is delivered throush the lumen 3~ of the cannula 28 with the blood passing through the annular area between the ca.nnula 28 and the aortic occlusion device 2. The oxygenated blood passing through the open end 42 of the cannula 28 is directed at the occluding member 4 so that the oxygenated blood is not directed at the wall of the aorta. An advantage of directing the oxygenated blood at the occluding member 4 is that the fluid is dispersed radially outward by the occluding member 4 before coming into contact with the wall of the aorta. By directing the blood at the occluding member 4, rather than at the wall of the aorta, the likelihood of releasing to emboli from the wall of the aorta may be reduced. Oxygenated blood is also directed through the side ports 44 so that oxygenated blood is delivered to the patient even if the occluding member 4 blocks the open end 42, of the cannula 28.
Referring to Figs. 13, another aortic occlusion device 2A is shown having a balloon 76 which is inflated with the oxygenated blood delivered to the patient. The aortic occlusion device 2A has a blood flow lumen 78 which is fluidly coupled to the interior of the balloon 76 for inflating the balloon 76. Oxygenated blood is then delivered to the patient through an opening 80, preferably a number of openings, in the balloon 76. An advantage of the aortic occlusion device 2A is that a separate inflation lumen is not required since occlusion is accomplished by simply delivering oxygenated blood through the aortic occlusion device 2A. The aortic occlusion device 2A may also include a pressure lumen 82 for measuring pressure in the ascending aorta and a lumen 84 for delivering cardioplege and venting the ascending aorta. The aortic occlusion device 2A is preferably formed. in the manner described above except that the lumen 78 is sized large enough to provide sufficient flow of oxygenated blood at an acceptable pressure. Acceptable blood flow rates and pressures are disclosed in the above-mentioned patents and patent applications which have been incorporated by reference. Although it is preferred to manufacture the device in the manner described above, the aortic occlusion device 2A may also simply be an extrusion or laminated structure. The balloon 76 is preferably made oi- silicone having a thickness of 3o between 0.005 and 0.009 inch.
The aortic occlusion catheter 2A passes through the cannula 28 so that oxygenated blood can be delivered to the patient when the aortic occlusion device 2A
is removed. The cannula 28 is preferably the c,annula 28 described above with the
Referring to Figs. 13, another aortic occlusion device 2A is shown having a balloon 76 which is inflated with the oxygenated blood delivered to the patient. The aortic occlusion device 2A has a blood flow lumen 78 which is fluidly coupled to the interior of the balloon 76 for inflating the balloon 76. Oxygenated blood is then delivered to the patient through an opening 80, preferably a number of openings, in the balloon 76. An advantage of the aortic occlusion device 2A is that a separate inflation lumen is not required since occlusion is accomplished by simply delivering oxygenated blood through the aortic occlusion device 2A. The aortic occlusion device 2A may also include a pressure lumen 82 for measuring pressure in the ascending aorta and a lumen 84 for delivering cardioplege and venting the ascending aorta. The aortic occlusion device 2A is preferably formed. in the manner described above except that the lumen 78 is sized large enough to provide sufficient flow of oxygenated blood at an acceptable pressure. Acceptable blood flow rates and pressures are disclosed in the above-mentioned patents and patent applications which have been incorporated by reference. Although it is preferred to manufacture the device in the manner described above, the aortic occlusion device 2A may also simply be an extrusion or laminated structure. The balloon 76 is preferably made oi- silicone having a thickness of 3o between 0.005 and 0.009 inch.
The aortic occlusion catheter 2A passes through the cannula 28 so that oxygenated blood can be delivered to the patient when the aortic occlusion device 2A
is removed. The cannula 28 is preferably the c,annula 28 described above with the
8 PCT/US99/01340 first arm 32 coupled to the source of oxygenated blood 7?. pressure monitor 68. and source of cardioplegic fluid via valve 86. Thus. cardioplegic fluid and oxygenated blood can be directed through the lumen 35 in the cannula 28 if the lumen 84 is not provided in the aortic occlusion catheter 2A. The cannula 28 has the hemostasis valve 36 to seal the space between the cannula 28 and aortic occlusion device 2A.
Referring to Fig. 14. yet another aortic ~~cclusion device 2B is shown. The aortic occlusion device 2B has the occluding member 4 and the inflation lumen coupled to the source of inflation fluid 66 for inflating the occluding member 4. The aortic occlusion device 2B also has a lumen 88 for delivering oxygenated blood to the to patient from the source of oxygenated blood 6~1. The shaft is preferably reinforced with a wire in the manner described above except that the lumen 88 is sized large enough to provide adequate blood flow to the patient at an acceptable pressure as discussed above. The cannula 28 is preferably the same as the cannula 28 described above and the aortic occlusion device 2B is introduced through the cannula 28 in the manner described below. The first arm 34 of the cannula 28 has the hemostasis valve 36 for receiving the aortic occlusion device 2E~. The second arm 32 is coupled to a valve 90 which determines whether cardioplegic fluid or oxygenated blood is delivered through the lumen 35 in the cannula 28. Valve 92 determines whether oxygenated blood is delivered through the lumen 35 in the cannula 28 or the lumen 88 2o in the aortic occlusion device 2B. An advantage of the aortic occlusion device 2B and cannula 28 is that bypass support can be provided before inflating the occluding member 4 and can also be maintained after the aortic occlusion device 2B is removed from the cannula 28.
Referring to Figs. 15, another aortic occlusion device 2C is shown. The aortic occlusion device 2C has a balloon 94 mounted to a side of a shaft 96. The aortic occlusion device 2C has an inflation lumen 98 for inflating the balloon 94 through inflation outlet 100 and a lumen 102 for delivering cardioplegic fluid from the source of cardioplegic fluid 64 and venting the ascending aorta using the vacuum source 70.
The aortic occlusion device 2C also has a blood flow lumen 104 for delivering oxygenated blood to the patient from the source of oxygenated blood 72. A
fluid path 106 passes through the balloon 94 which is in fluid communication with the lumen 102 so that cardioplegic fluid is delivered through the fluid path 106 in the balloon 94.
An advantage of the aortic occlusion device :2,C is that the cardioplegic fluid can be
Referring to Fig. 14. yet another aortic ~~cclusion device 2B is shown. The aortic occlusion device 2B has the occluding member 4 and the inflation lumen coupled to the source of inflation fluid 66 for inflating the occluding member 4. The aortic occlusion device 2B also has a lumen 88 for delivering oxygenated blood to the to patient from the source of oxygenated blood 6~1. The shaft is preferably reinforced with a wire in the manner described above except that the lumen 88 is sized large enough to provide adequate blood flow to the patient at an acceptable pressure as discussed above. The cannula 28 is preferably the same as the cannula 28 described above and the aortic occlusion device 2B is introduced through the cannula 28 in the manner described below. The first arm 34 of the cannula 28 has the hemostasis valve 36 for receiving the aortic occlusion device 2E~. The second arm 32 is coupled to a valve 90 which determines whether cardioplegic fluid or oxygenated blood is delivered through the lumen 35 in the cannula 28. Valve 92 determines whether oxygenated blood is delivered through the lumen 35 in the cannula 28 or the lumen 88 2o in the aortic occlusion device 2B. An advantage of the aortic occlusion device 2B and cannula 28 is that bypass support can be provided before inflating the occluding member 4 and can also be maintained after the aortic occlusion device 2B is removed from the cannula 28.
Referring to Figs. 15, another aortic occlusion device 2C is shown. The aortic occlusion device 2C has a balloon 94 mounted to a side of a shaft 96. The aortic occlusion device 2C has an inflation lumen 98 for inflating the balloon 94 through inflation outlet 100 and a lumen 102 for delivering cardioplegic fluid from the source of cardioplegic fluid 64 and venting the ascending aorta using the vacuum source 70.
The aortic occlusion device 2C also has a blood flow lumen 104 for delivering oxygenated blood to the patient from the source of oxygenated blood 72. A
fluid path 106 passes through the balloon 94 which is in fluid communication with the lumen 102 so that cardioplegic fluid is delivered through the fluid path 106 in the balloon 94.
An advantage of the aortic occlusion device :2,C is that the cardioplegic fluid can be
9 PCT/US99/01340 delivered toward the aortic valve while oxv~enated blood is directed in the direction of normal blood tow in the aortic arch. The distal end of the aortic occlusion device has an open end 108 and side ports 1 10 through which the oxygenated blood is delivered. The aortic occlusion device 2C also includes the ring 46 which is the same as the ring 46 described above. The aortic occlusion device 2C may be manufactured in any manner such as the manner described above or as a simple extrusion or laminated structure.
Referring to Fig. 16, the aortic occlusion device 2 is shown passing through a side port 112 of a cannula 28D. The side port 112 facilitates positioning the occluding l0 member 4 in the ascending aorta. The aortic occlusion device 2 is preferably the aortic occlusion device 2 described above. The aortic occlusion device 2 passes through a lumen 114 in the cannula 28D. The lumen I 14 is coupled to the source of oxygenated blood 72 so that the oxygenated blood is delivered through the annular area between the aortic occlusion device 2 and the wall of the lumen i 14. The lumen t5 114 has an open end 116 with a cross-member 118 which prevents the aortic occlusion catheter 2 from passing through the open end 116. An advantage of the side port 112 is that the aortic occlusion device 2 is. directed into the ascending aorta while blood passing through the lumen 114 is directc;d in the direction of normal blood flow in the aorta.
20 Referring to Figs. 18 and 19, another aortic occlusion device 2E is shown.
The aortic occlusion device 2E is similar to the aot2ic occlusion device 2A of Fig. l3 in that balloon 130 is inflated with oxygenated blood delivered from the source of oxygenated blood 72. Oxygenated blood is delivered to the patient through a lumen 132 and an open end 134 of the aortic occlusion device 2E. As will be described 25 below, the interior of the balloon 130 is fluidly coupled to the lumen 132 through an inflation hole 133 for inflating the balloon 130 when blood is delivered through the lumen 132.
The aortic occlusion device 2E includca a body 136 having the y-arm connector 30 described above. A sleeve 138 :is positioned in the lumen 132 to control 3o inflation and deflation of the balloon 130. Blood passing through the lumen passes through the sleeve 138 so that the sleeve 138 does not interfere with delivery of oxygenated blood to the patient. The sleeve 1.38 is attached to a rod 140 which is manipulated to move the sleeve i 38 between the positions of Figs. 18 and 19.
The WO 99/37202 ~ 0 PCT/US99/01340 sleeve 138 has a hole 142 which is alligned with the inflation hole 133 as shown in Fig. 18 to t7uidly couple the interior of the balloon 130 with the lumen 13~.
When the sleeve 138 is advanced to the position of Fig. I!~, the hole I42 is not alligned with the inflation lumen 133 and the sleeve 138 covers the inflation hole 133 so that the interior of the balloon 130 is not tluidly coupled to the lumen 132.
The sleeve 138 permits the surgeon to control inflation and deflation of the balloon 130. After introduction of the aortic occlusion device 2E. bypass support is generally initiated before inflating the balloon 130. This can be accomplished by maintaining the sleeve 138 in the position of Fig. 19 so that the balloon 130 is not inflated by the blood delivered through the lumen 132. When it is desired to inflate the balloon 130 and occlude the ascending aorta, the sleeve 138 is moved to the position of Fig. 18 so that the balloon 130 is inllated with blood. The sleeve 138 also permits the surgeon to maintain full occlusion of the ascending aorta even when blood flow is reduced to a level which would not provide sufficient pressure to inflate the i5 balloon to maintain full occlusion of the aorta. In order to maintain occlusion at low flow rates, the sleeve 138 is moved to the position of Fig. 19 before reducing the blood flow rate so that the balloon 130 will remain inflated when the delivery pressure drops. Finally, the sleeve 138 also permits the surgeon to maintain bypass support with a deflated balloon 130 after the surgical procedure is completed. In order to 2o maintain deflation of the balloon while delivering blood, the blood flow rate is reduced to deflate the balloon 130, the sleeve i~ moved to the position of Fig. 19 to deflate the balloon, and the blood flow rate is then increased. The sleeve 138 prevents the balloon l30 from inflating when the blood flow rate is increased.
The body 136 may be made in any suitable manner and is preferably 25 manufactured similar to the cannula 28 of Fig. 6. A support tube 144 is attached to the body and the balloon 130 is mounted to thf; support tube. A soft tip 145 is attached to the distal end of the support tube 144 to provide an atraumatic distal end to prevent injury during introduction of the device 2E. The sleeve 138 may be made of any suitable material and is preferably a urethane tube. The rod 140 may also be made 30 of any suitable material and is preferably urethane coated polyamide.
Although it is preferred to provide the sleeve 138 between the interior of the balloon 130 and the lumen 132 any other device may be used such as a valve, balloon or plug.
Use of the cannula and aortic occlusion device ? is now described in connection with Figs. 12 and 17. The description below is applicable to all cannulae 28, 28D and aortic occlusion devices 2. 2A. 2B. 2C described herein. Although the method described below is for direct insertion of the cannula 28 and aortic occlusion device 2 into the aortic arch. the cannula 28 and aortic occlusion device 2 may also be introduced through a peripheral artery such as the femoral. subclavian or axillary arteries as described in U.S. Patent No. 5.484,803.
Before introduction of the cannula, a rib retractor 120 or other device is used to form an opening in an intercostal space such as the 4'" intercostal space.
The t0 opening through the intercostal space is used far access to perform a surgical procedure such as a valve repair or replacement. The opening also provides direct access to the ascending aorta for control of the ascending aorta and to place purse-string sutures in the aorta.
An incision is also created in the ls' or :Z"'~ intercostal space in which an 11.5 ~5 mm trocar 122 is positioned. The cannula 28 is then introduced through the trocar 122 and advanced to the surface of the aorta with the introduces 50 (see Figs.
Referring to Fig. 16, the aortic occlusion device 2 is shown passing through a side port 112 of a cannula 28D. The side port 112 facilitates positioning the occluding l0 member 4 in the ascending aorta. The aortic occlusion device 2 is preferably the aortic occlusion device 2 described above. The aortic occlusion device 2 passes through a lumen 114 in the cannula 28D. The lumen I 14 is coupled to the source of oxygenated blood 72 so that the oxygenated blood is delivered through the annular area between the aortic occlusion device 2 and the wall of the lumen i 14. The lumen t5 114 has an open end 116 with a cross-member 118 which prevents the aortic occlusion catheter 2 from passing through the open end 116. An advantage of the side port 112 is that the aortic occlusion device 2 is. directed into the ascending aorta while blood passing through the lumen 114 is directc;d in the direction of normal blood flow in the aorta.
20 Referring to Figs. 18 and 19, another aortic occlusion device 2E is shown.
The aortic occlusion device 2E is similar to the aot2ic occlusion device 2A of Fig. l3 in that balloon 130 is inflated with oxygenated blood delivered from the source of oxygenated blood 72. Oxygenated blood is delivered to the patient through a lumen 132 and an open end 134 of the aortic occlusion device 2E. As will be described 25 below, the interior of the balloon 130 is fluidly coupled to the lumen 132 through an inflation hole 133 for inflating the balloon 130 when blood is delivered through the lumen 132.
The aortic occlusion device 2E includca a body 136 having the y-arm connector 30 described above. A sleeve 138 :is positioned in the lumen 132 to control 3o inflation and deflation of the balloon 130. Blood passing through the lumen passes through the sleeve 138 so that the sleeve 138 does not interfere with delivery of oxygenated blood to the patient. The sleeve 1.38 is attached to a rod 140 which is manipulated to move the sleeve i 38 between the positions of Figs. 18 and 19.
The WO 99/37202 ~ 0 PCT/US99/01340 sleeve 138 has a hole 142 which is alligned with the inflation hole 133 as shown in Fig. 18 to t7uidly couple the interior of the balloon 130 with the lumen 13~.
When the sleeve 138 is advanced to the position of Fig. I!~, the hole I42 is not alligned with the inflation lumen 133 and the sleeve 138 covers the inflation hole 133 so that the interior of the balloon 130 is not tluidly coupled to the lumen 132.
The sleeve 138 permits the surgeon to control inflation and deflation of the balloon 130. After introduction of the aortic occlusion device 2E. bypass support is generally initiated before inflating the balloon 130. This can be accomplished by maintaining the sleeve 138 in the position of Fig. 19 so that the balloon 130 is not inflated by the blood delivered through the lumen 132. When it is desired to inflate the balloon 130 and occlude the ascending aorta, the sleeve 138 is moved to the position of Fig. 18 so that the balloon 130 is inllated with blood. The sleeve 138 also permits the surgeon to maintain full occlusion of the ascending aorta even when blood flow is reduced to a level which would not provide sufficient pressure to inflate the i5 balloon to maintain full occlusion of the aorta. In order to maintain occlusion at low flow rates, the sleeve 138 is moved to the position of Fig. 19 before reducing the blood flow rate so that the balloon 130 will remain inflated when the delivery pressure drops. Finally, the sleeve 138 also permits the surgeon to maintain bypass support with a deflated balloon 130 after the surgical procedure is completed. In order to 2o maintain deflation of the balloon while delivering blood, the blood flow rate is reduced to deflate the balloon 130, the sleeve i~ moved to the position of Fig. 19 to deflate the balloon, and the blood flow rate is then increased. The sleeve 138 prevents the balloon l30 from inflating when the blood flow rate is increased.
The body 136 may be made in any suitable manner and is preferably 25 manufactured similar to the cannula 28 of Fig. 6. A support tube 144 is attached to the body and the balloon 130 is mounted to thf; support tube. A soft tip 145 is attached to the distal end of the support tube 144 to provide an atraumatic distal end to prevent injury during introduction of the device 2E. The sleeve 138 may be made of any suitable material and is preferably a urethane tube. The rod 140 may also be made 30 of any suitable material and is preferably urethane coated polyamide.
Although it is preferred to provide the sleeve 138 between the interior of the balloon 130 and the lumen 132 any other device may be used such as a valve, balloon or plug.
Use of the cannula and aortic occlusion device ? is now described in connection with Figs. 12 and 17. The description below is applicable to all cannulae 28, 28D and aortic occlusion devices 2. 2A. 2B. 2C described herein. Although the method described below is for direct insertion of the cannula 28 and aortic occlusion device 2 into the aortic arch. the cannula 28 and aortic occlusion device 2 may also be introduced through a peripheral artery such as the femoral. subclavian or axillary arteries as described in U.S. Patent No. 5.484,803.
Before introduction of the cannula, a rib retractor 120 or other device is used to form an opening in an intercostal space such as the 4'" intercostal space.
The t0 opening through the intercostal space is used far access to perform a surgical procedure such as a valve repair or replacement. The opening also provides direct access to the ascending aorta for control of the ascending aorta and to place purse-string sutures in the aorta.
An incision is also created in the ls' or :Z"'~ intercostal space in which an 11.5 ~5 mm trocar 122 is positioned. The cannula 28 is then introduced through the trocar 122 and advanced to the surface of the aorta with the introduces 50 (see Figs.
10 and
11 ) positioned in the lumen 35 of the cannula :!8 to determine the appropriate orientation of the cannula 28. The distal end of the introduces 50 is then moved into contact with the aorta about l -2 cm below the origin of the innominate artery to 20 identify the appropriate location for purse-string sutures 124. The surgeon then places two purse-string sutures 124 around the site. '1.'he ends of the purse-string sutures 124 are passed through tubes 126 which are used to tension the purse-string sutures 124.
The purse-string sutures 124 are then passed through the slots 48 in the ring 46.
The cannula 28 is then advanced into contact with the aorta at the site now 25 surrounded by the purse-string sutures 124. T;he surgeon then incises the aorta with the incising element 52 of the introduces 50 or with a separate incising instrument.
The cannula 28 is then immediately advanced through the incision until the ring 46 engages the aorta. The radiopaque marker 45 may be viewed under fluoroscopy and the cannula 28 manipulated until the beveled t.ip is directed toward the aortic valve.
30 Alternatively, the tip orientation may be determined by TEE. The purse-string 124 sutures are then tensioned to seal around the cannula 28. The aortic occlusion device 2 is then passed through the hemostasis valve 36 and advanced until the occluding member 4 is positioned in the ascending aorta. Delivery of oxygenated blood, WO 99/37202 ~ 2 PCT/US99/01340 occlusion of the ascending aorta and delivery of cardiople~ic t7uid is then performed in the manner described in U.S. Patent No. 5.484.803.
Referrine now to Fias. 20-24. a cannula 28F is shown wherein the same or similar reference numbers refer to the same or similar structure. The cannula 28F may be used with any of the catheters and cannulae described herein and. thus, the features of the cannula 28F may be included in any of the cannulae or catheters described herein without departing from the invention. For example, the cannula 28F may receive the aortic occlusion catheter 2 (Fig. 24) or have the aortic occlusion member 4 (see Fig. 25). The cannula 28F may also be used to simply deliver blood in to conventional open-chest surgery where an external cross-clamp is used to occlude the ascending aorta.
The cannula 28F is similar to the cannula 28 described above except that the cannula 28F has a curved or angled distal portion 130 when in the natural, unbiased shape of Figs. 20 and 21. An advantage of the curved or angled distal portion 130 is t5 that fluids, such as blood, may be infused or withdrawn from a passageway with the cannula 28F directed with or against natural flow. Another advantage of the curved or angled distal end 130 is that the cannula 28F is centered in the vessel so that fluid infused through the cannula 28F is not directed at a wall. The cannula also helps to center the catheter 2 extending from the distal end of the cannula 28F.
Centering the 2o catheter 2 ensures that the distal tip of the catheter 2 is centered in the vessel rather than directed at a vessel wall to facilitate fluid infusion or venting through the catheter 2 as described above. The distal portion 130 al;~o helps anchor the catheter 2 and occluding member 4 in the vessel to resist migration of the catheter 2 and distortion of the occluding member 4.
25 Referring to Fig. 22, the introduces 50 straightens the distal portion 130 of the cannula 28F for introduction of the cannula 281;~ into a vessel. The straightened configuration facilitates introduction since the c:annula 28F is advanced into the vessel with simple linear motion from the proximal end of the device. Although it is preferred to use the introduces 50 described above, any other suitable introduces may 3o be used including an introduces without an incising element. The cannula preferably includes the y-arm connector 30 having the first and second arms 32. 34 each coupled to the lumen 35. The y-arm connector 30 has the hemostasis valve for receiving a catheter such as any of the aortic occlusion catheters 2. 2A.
WO 99/37202 ~ 3 PCT/US99/01340 described herein. The cannula ''8F is preterabl;y manufactured in substantially the same manner as cannula 28 described above. however. cannula 28F may be also made in anv other suitable manner such as extrusion molding.
Use of the cannula 28F is now described in connection with Figs. 23 and 24.
As mentioned above, all features of the cannula 28F may be included in any of the cannulae and catheters described herein and description of the method is applicable to all of the cannulae and catheters. Purse-string sutures (not shown) are sewn in the aorta to provide hemostasis around the cannula. The cannula 28F is moved toward the aorta and the incising element 52 (see Fig. 11 ) is extended to incise the aorta. The cannula 28F is then advanced into the aorta, the incising element 52 is retracted and the purse-string sutures are tensioned. The introduces 50 is then removed which permits the distal portion 130 of the cannula 2l3F to curve or angle in the manner shown in Fig. 24. Catheters, such as the aortic occlusion device 2, can then be advanced into the aorta as described above for occlusion of the aorta, delivery of cardioplegic fluid and return of oxygenated blood. Alternatively, the cannula 28F may be oriented downstream to simply deliver blood from a bypass system. Referring to Fig. 25, another cannula 28G is shown which includes the occluding member 4 and lumen 132 for venting and delivery of cardioplegic fluid.
Referring to Figs. 26 and 27, another cannula 28H is shown wherein the same or similar reference numbers refer to the same or similar structure. The cannula 28H
has an angled shape to move the shaft out of the surgical field and away from the surgeon so that the cannula 28H does not interfere with the procedure. The angled shape is particularly useful when introducing the cannula 28H through small incisions between the ribs such as an incision in the first: or second intercostal space. The cannula 28H may, of course, be introduced through a median sternotomy, thoracotomy or other surgical incision without departing from the scope of the invention.
The cannula 28H has a first section I50 extending from the y-arm connector to a second section 152 which is angled with respect to the first section 150.
The second section 152 extends for 2-6 cm and more preferably 3-4 cm from a distal end 3o 154. The first section 1 SO forms an angle a with the second section 152 of about 110 to 140 degrees and more preferably about 125 degrees. The stabilizing ring 46H
is mounted to the first section 150 and preferably forms an angle ~i of about 45 to 85 degrees and more preferably about 60-75 degrees with the first section 150.
The ring WO 99/37202 ~ 4 PCT/US99/01340 -16H is preferably attached to the second section 1 i? about 3--1 cm from the distal end 154. The cannula 28H may be used as a substitute for anv of the other cannulae described herein and. thus, the cannula 28H may receive catheters 2. ?:~. 2B, have the occluding member 4 or may be used to simply return blood to the patient from a bypass system. The cannula 28H may be manufactured in any suitable manner and is preferably manufactured in a substantially similar manner to the cannula 28 described above.
Another aortic occlusion device 2J is now described in connection with Figs.
28-30 wherein the same or similar reference numbers describe the same or similar t0 structure. The aortic occlusion device 2J incluf~es a balloon 160 having a first, smaller section 162 and a second, larger section 164. The first section 162 minimizes the amount of space that the balloon 160 occupies in the aorta to maximize space in the aorta for performing aortic valve procedures and proximal anastomoses in coronary artery bypass procedures. The second section 164 stabilizes the first section 162 so that the first section 162 remains stable in the aorta. If the balloon 160 was discoid, for example, the balloon 160 may become unstable in the aorta and partially flip to one side or the other. Flipping or distortion of the balloon 160 can prevent full occlusion of the aorta which would allow warm, oxygenated blood to reach the patient's coronary arteries and possibly start the: patient's heart beating before the 2o procedure is completed.
Referring to the end view of Fig. 29, the: second section 164 expands to a semi-circular profile with a top portion 166 of the second section 164 bonded to the shaft. The second section 164 preferably extends about 180 degrees around the cannula, however, the second section 164 may extend anywhere between 90 degrees and 230 degrees around the cannula shaft.
A cross-sectional view of the aortic occlusion device 2J is shown in Fig. 30.
The aortic occlusion device 2J is preferably wire-reinforced in the manner described above, however, the aortic occlusion device 2J may be manufactured in any other suitable manner. The aortic occlusion device 2J includes a lumen 165 having an outlet to return oxygenated blood to the patient. The aortic occlusion device 2J also has a lumen 166 to deliver cardioplegic fluid and vent the aorta and a lumen 167 to inflate the balloon 160. The lumen 166 may also receive a vent catheter 168 which passes into the ascending aorta to vent blood from the ascending aorta as described above.
The first and second sections 162. 164 may be positioned around the aortic occlusion device 2J in any orientation depending upon the angle and location that the 5 cannula 2J is introduced into the aorta. The second section 164 is preferably positioned diametrically opposite the head and neck vessels so that the head and neck vessels are not blocked. Fig. 3I shows the first and second sections 162. 164 switched for use when the cannula is introduced from an inferior location. Figs. 32 and show yet another embodiment where the first a.nd second sections 162, 164 are on t0 opposite sides of the cannula. The aortic occlusion device 2J may, of course, take any of the forms described herein. For example, the orientation of the device ZJ
may be reversed so that blood passes through the lumen 166 and cardioplegic fluid is delivered through the lumen 165. The aortic occlusion device 2J may also be configured with the separate arterial cannula 2.3 (Fig. 12) rather than having the lumen t5 165 integrated into the device 2J.
Referring to Fig. 34, another aortic occlusion device 2K is shown wherein like or similar reference numbers refer to like or similar structure. The aortic occlusion device ZK has a thin, discoid occluding member 4K, which is preferably a balloon, stabilized and supported by a stabilizer 170. A,s mentioned above, the discoid occluding member 4K may be unstable in the aorta which can cause a portion of the occluding member to flip or otherwise distort thereby preventing full occlusion of the aorta. The stabilizer 170 supports and stabilizes the occluding member 4K
thereby preventing the discoid occluding member 4K from flipping or distorting. The stabilizer 170 is positioned adjacent the occluding member to engage and contact the occluding member 4K.
The stabilizer 170 is preferably an open mesh 172 when in the expanded condition which permits blood flow to the head and neck vessels. An advantage of the stabilizer 170 is that the discoid occluding member 4K can be moved closer to the head and neck vessels to provide more room in the aorta to perform surgical procedures. Although the stabilizer 1.70 preferably has a woven or mesh structure, the stabilizer 170 may also be a perforated tube or an expanding basket or cone without departing from the scope of the invention.
*rB
WO 99/37202 ~ 6 PCT/US99/01340 The device ?K has the arterial cannula 2B and the aortic occlusion device ?B
described above and the system may. of course, have anv of the other suitable cannula and/or catheter configuration. The aortic occlusion device 2K includes another y-arm connector 174 having a hemostasis valve 176 which receives the stabilizer 170.
The stabilizer 170 is preferably independent of the shaft supporting the occluding member 4K but may also be integrally formed with the shaft to which the occluding member 4K is attached.
Referring to Figs. 35 and 36, the stabilizer 170 includes a shaft 178 having a passageway 180 which receives a wire 182 which is pulled to move the stabilizer 170 t0 to the expanded condition of Fig. 36. A proximal end 184 of the mesh 172 is attached to a distal end 186 of the shaft 178 and a distal end 188 of the mesh 172 is attached to the wire 182. The stabilizer 170 is naturally biased to the contracted position of Fig.
35 so that the stabilizer 170 is collapsed by simply releasing tension on the wire 182.
The mesh 172 is preferably made of stainless steel wire or a plastic braid, although any suitable material may be used.
Although the method described above positions the aortic occlusion device through an opening separate from the opening through which the surgeon operates, the cannula and aortic occlusion device 2 may also be introduced through the same opening through which the surgeon operates. The choice of opening location, number 2o and size are a matter of surgical choice depending upon patient anatomy, the medical procedure being performed. surgeon preference and the particular embodiment of the invention being used. Furthermore, the devices described herein may have application in other parts of the heart and in other parts of the body. Thus, the description of the specific procedure described above is merely an example and other surgical methods may be used with the devices and methods of the present invention.
The purse-string sutures 124 are then passed through the slots 48 in the ring 46.
The cannula 28 is then advanced into contact with the aorta at the site now 25 surrounded by the purse-string sutures 124. T;he surgeon then incises the aorta with the incising element 52 of the introduces 50 or with a separate incising instrument.
The cannula 28 is then immediately advanced through the incision until the ring 46 engages the aorta. The radiopaque marker 45 may be viewed under fluoroscopy and the cannula 28 manipulated until the beveled t.ip is directed toward the aortic valve.
30 Alternatively, the tip orientation may be determined by TEE. The purse-string 124 sutures are then tensioned to seal around the cannula 28. The aortic occlusion device 2 is then passed through the hemostasis valve 36 and advanced until the occluding member 4 is positioned in the ascending aorta. Delivery of oxygenated blood, WO 99/37202 ~ 2 PCT/US99/01340 occlusion of the ascending aorta and delivery of cardiople~ic t7uid is then performed in the manner described in U.S. Patent No. 5.484.803.
Referrine now to Fias. 20-24. a cannula 28F is shown wherein the same or similar reference numbers refer to the same or similar structure. The cannula 28F may be used with any of the catheters and cannulae described herein and. thus, the features of the cannula 28F may be included in any of the cannulae or catheters described herein without departing from the invention. For example, the cannula 28F may receive the aortic occlusion catheter 2 (Fig. 24) or have the aortic occlusion member 4 (see Fig. 25). The cannula 28F may also be used to simply deliver blood in to conventional open-chest surgery where an external cross-clamp is used to occlude the ascending aorta.
The cannula 28F is similar to the cannula 28 described above except that the cannula 28F has a curved or angled distal portion 130 when in the natural, unbiased shape of Figs. 20 and 21. An advantage of the curved or angled distal portion 130 is t5 that fluids, such as blood, may be infused or withdrawn from a passageway with the cannula 28F directed with or against natural flow. Another advantage of the curved or angled distal end 130 is that the cannula 28F is centered in the vessel so that fluid infused through the cannula 28F is not directed at a wall. The cannula also helps to center the catheter 2 extending from the distal end of the cannula 28F.
Centering the 2o catheter 2 ensures that the distal tip of the catheter 2 is centered in the vessel rather than directed at a vessel wall to facilitate fluid infusion or venting through the catheter 2 as described above. The distal portion 130 al;~o helps anchor the catheter 2 and occluding member 4 in the vessel to resist migration of the catheter 2 and distortion of the occluding member 4.
25 Referring to Fig. 22, the introduces 50 straightens the distal portion 130 of the cannula 28F for introduction of the cannula 281;~ into a vessel. The straightened configuration facilitates introduction since the c:annula 28F is advanced into the vessel with simple linear motion from the proximal end of the device. Although it is preferred to use the introduces 50 described above, any other suitable introduces may 3o be used including an introduces without an incising element. The cannula preferably includes the y-arm connector 30 having the first and second arms 32. 34 each coupled to the lumen 35. The y-arm connector 30 has the hemostasis valve for receiving a catheter such as any of the aortic occlusion catheters 2. 2A.
WO 99/37202 ~ 3 PCT/US99/01340 described herein. The cannula ''8F is preterabl;y manufactured in substantially the same manner as cannula 28 described above. however. cannula 28F may be also made in anv other suitable manner such as extrusion molding.
Use of the cannula 28F is now described in connection with Figs. 23 and 24.
As mentioned above, all features of the cannula 28F may be included in any of the cannulae and catheters described herein and description of the method is applicable to all of the cannulae and catheters. Purse-string sutures (not shown) are sewn in the aorta to provide hemostasis around the cannula. The cannula 28F is moved toward the aorta and the incising element 52 (see Fig. 11 ) is extended to incise the aorta. The cannula 28F is then advanced into the aorta, the incising element 52 is retracted and the purse-string sutures are tensioned. The introduces 50 is then removed which permits the distal portion 130 of the cannula 2l3F to curve or angle in the manner shown in Fig. 24. Catheters, such as the aortic occlusion device 2, can then be advanced into the aorta as described above for occlusion of the aorta, delivery of cardioplegic fluid and return of oxygenated blood. Alternatively, the cannula 28F may be oriented downstream to simply deliver blood from a bypass system. Referring to Fig. 25, another cannula 28G is shown which includes the occluding member 4 and lumen 132 for venting and delivery of cardioplegic fluid.
Referring to Figs. 26 and 27, another cannula 28H is shown wherein the same or similar reference numbers refer to the same or similar structure. The cannula 28H
has an angled shape to move the shaft out of the surgical field and away from the surgeon so that the cannula 28H does not interfere with the procedure. The angled shape is particularly useful when introducing the cannula 28H through small incisions between the ribs such as an incision in the first: or second intercostal space. The cannula 28H may, of course, be introduced through a median sternotomy, thoracotomy or other surgical incision without departing from the scope of the invention.
The cannula 28H has a first section I50 extending from the y-arm connector to a second section 152 which is angled with respect to the first section 150.
The second section 152 extends for 2-6 cm and more preferably 3-4 cm from a distal end 3o 154. The first section 1 SO forms an angle a with the second section 152 of about 110 to 140 degrees and more preferably about 125 degrees. The stabilizing ring 46H
is mounted to the first section 150 and preferably forms an angle ~i of about 45 to 85 degrees and more preferably about 60-75 degrees with the first section 150.
The ring WO 99/37202 ~ 4 PCT/US99/01340 -16H is preferably attached to the second section 1 i? about 3--1 cm from the distal end 154. The cannula 28H may be used as a substitute for anv of the other cannulae described herein and. thus, the cannula 28H may receive catheters 2. ?:~. 2B, have the occluding member 4 or may be used to simply return blood to the patient from a bypass system. The cannula 28H may be manufactured in any suitable manner and is preferably manufactured in a substantially similar manner to the cannula 28 described above.
Another aortic occlusion device 2J is now described in connection with Figs.
28-30 wherein the same or similar reference numbers describe the same or similar t0 structure. The aortic occlusion device 2J incluf~es a balloon 160 having a first, smaller section 162 and a second, larger section 164. The first section 162 minimizes the amount of space that the balloon 160 occupies in the aorta to maximize space in the aorta for performing aortic valve procedures and proximal anastomoses in coronary artery bypass procedures. The second section 164 stabilizes the first section 162 so that the first section 162 remains stable in the aorta. If the balloon 160 was discoid, for example, the balloon 160 may become unstable in the aorta and partially flip to one side or the other. Flipping or distortion of the balloon 160 can prevent full occlusion of the aorta which would allow warm, oxygenated blood to reach the patient's coronary arteries and possibly start the: patient's heart beating before the 2o procedure is completed.
Referring to the end view of Fig. 29, the: second section 164 expands to a semi-circular profile with a top portion 166 of the second section 164 bonded to the shaft. The second section 164 preferably extends about 180 degrees around the cannula, however, the second section 164 may extend anywhere between 90 degrees and 230 degrees around the cannula shaft.
A cross-sectional view of the aortic occlusion device 2J is shown in Fig. 30.
The aortic occlusion device 2J is preferably wire-reinforced in the manner described above, however, the aortic occlusion device 2J may be manufactured in any other suitable manner. The aortic occlusion device 2J includes a lumen 165 having an outlet to return oxygenated blood to the patient. The aortic occlusion device 2J also has a lumen 166 to deliver cardioplegic fluid and vent the aorta and a lumen 167 to inflate the balloon 160. The lumen 166 may also receive a vent catheter 168 which passes into the ascending aorta to vent blood from the ascending aorta as described above.
The first and second sections 162. 164 may be positioned around the aortic occlusion device 2J in any orientation depending upon the angle and location that the 5 cannula 2J is introduced into the aorta. The second section 164 is preferably positioned diametrically opposite the head and neck vessels so that the head and neck vessels are not blocked. Fig. 3I shows the first and second sections 162. 164 switched for use when the cannula is introduced from an inferior location. Figs. 32 and show yet another embodiment where the first a.nd second sections 162, 164 are on t0 opposite sides of the cannula. The aortic occlusion device 2J may, of course, take any of the forms described herein. For example, the orientation of the device ZJ
may be reversed so that blood passes through the lumen 166 and cardioplegic fluid is delivered through the lumen 165. The aortic occlusion device 2J may also be configured with the separate arterial cannula 2.3 (Fig. 12) rather than having the lumen t5 165 integrated into the device 2J.
Referring to Fig. 34, another aortic occlusion device 2K is shown wherein like or similar reference numbers refer to like or similar structure. The aortic occlusion device ZK has a thin, discoid occluding member 4K, which is preferably a balloon, stabilized and supported by a stabilizer 170. A,s mentioned above, the discoid occluding member 4K may be unstable in the aorta which can cause a portion of the occluding member to flip or otherwise distort thereby preventing full occlusion of the aorta. The stabilizer 170 supports and stabilizes the occluding member 4K
thereby preventing the discoid occluding member 4K from flipping or distorting. The stabilizer 170 is positioned adjacent the occluding member to engage and contact the occluding member 4K.
The stabilizer 170 is preferably an open mesh 172 when in the expanded condition which permits blood flow to the head and neck vessels. An advantage of the stabilizer 170 is that the discoid occluding member 4K can be moved closer to the head and neck vessels to provide more room in the aorta to perform surgical procedures. Although the stabilizer 1.70 preferably has a woven or mesh structure, the stabilizer 170 may also be a perforated tube or an expanding basket or cone without departing from the scope of the invention.
*rB
WO 99/37202 ~ 6 PCT/US99/01340 The device ?K has the arterial cannula 2B and the aortic occlusion device ?B
described above and the system may. of course, have anv of the other suitable cannula and/or catheter configuration. The aortic occlusion device 2K includes another y-arm connector 174 having a hemostasis valve 176 which receives the stabilizer 170.
The stabilizer 170 is preferably independent of the shaft supporting the occluding member 4K but may also be integrally formed with the shaft to which the occluding member 4K is attached.
Referring to Figs. 35 and 36, the stabilizer 170 includes a shaft 178 having a passageway 180 which receives a wire 182 which is pulled to move the stabilizer 170 t0 to the expanded condition of Fig. 36. A proximal end 184 of the mesh 172 is attached to a distal end 186 of the shaft 178 and a distal end 188 of the mesh 172 is attached to the wire 182. The stabilizer 170 is naturally biased to the contracted position of Fig.
35 so that the stabilizer 170 is collapsed by simply releasing tension on the wire 182.
The mesh 172 is preferably made of stainless steel wire or a plastic braid, although any suitable material may be used.
Although the method described above positions the aortic occlusion device through an opening separate from the opening through which the surgeon operates, the cannula and aortic occlusion device 2 may also be introduced through the same opening through which the surgeon operates. The choice of opening location, number 2o and size are a matter of surgical choice depending upon patient anatomy, the medical procedure being performed. surgeon preference and the particular embodiment of the invention being used. Furthermore, the devices described herein may have application in other parts of the heart and in other parts of the body. Thus, the description of the specific procedure described above is merely an example and other surgical methods may be used with the devices and methods of the present invention.
Claims (26)
1. An arterial cannula assembly for perfusion of blood into a patient, comprising:
an arterial cannula having a blood flow lumen; and an introduces removably received in the blood flow lumen:
the arterial cannula having a first shape when the introduces is positioned in the blood flow lumen, the arterial cannula having a second shape when the introduces is removed from the blood flow lumen.
an arterial cannula having a blood flow lumen; and an introduces removably received in the blood flow lumen:
the arterial cannula having a first shape when the introduces is positioned in the blood flow lumen, the arterial cannula having a second shape when the introduces is removed from the blood flow lumen.
2. The arterial cannula assembly of claim 1, wherein:
the arterial cannula is L-shaped when in the second shape.
the arterial cannula is L-shaped when in the second shape.
3. The arterial cannula assembly of claim 1, wherein:
the arterial cannula is curved when in the second shape.
the arterial cannula is curved when in the second shape.
4. The arterial cannula assembly of claim 1, wherein:
the introduces has a cutting element, the cutting element being movable from a retracted position to an extended position, the cutting element extending beyond a distal end of the introduces when in the extended position.
the introduces has a cutting element, the cutting element being movable from a retracted position to an extended position, the cutting element extending beyond a distal end of the introduces when in the extended position.
5. The arterial cannula assembly of claim 1, further comprising:
a catheter slidably received by the arterial cannula.
a catheter slidably received by the arterial cannula.
6. The arterial cannula assembly of claim 1, wherein:
the catheter has a balloon for occluding the ascending aorta.
the catheter has a balloon for occluding the ascending aorta.
7. The arterial cannula assembly of claim 1, wherein:
the arterial cannula has a second lumen, the catheter being slidably positioned in the second lumen.
the arterial cannula has a second lumen, the catheter being slidably positioned in the second lumen.
8. A method of cannulating a patient's ascending aorta, comprising the steps of:
providing an arterial cannula and an introducer, the arterial cannula having a blood flow lumen and a distal end;
introducing the arterial cannula into the ascending aorta, the introduces being positioned in the blood flow lumen and extending beyond the distal end of the arterial cannula, the arterial cannula being in a first shape during the introducing step;
withdrawing the introduces from the blood flow lumen after the introducing step, the arterial cannula having a second shape after the introduces has been withdrawn from the blood flow lumen;
coupling the blood flow lumen to a source of oxygenated blood: and perfusing the oxygenated blood into the patient through the blood flow lumen.
providing an arterial cannula and an introducer, the arterial cannula having a blood flow lumen and a distal end;
introducing the arterial cannula into the ascending aorta, the introduces being positioned in the blood flow lumen and extending beyond the distal end of the arterial cannula, the arterial cannula being in a first shape during the introducing step;
withdrawing the introduces from the blood flow lumen after the introducing step, the arterial cannula having a second shape after the introduces has been withdrawn from the blood flow lumen;
coupling the blood flow lumen to a source of oxygenated blood: and perfusing the oxygenated blood into the patient through the blood flow lumen.
9. The method of claim 8, further comprising the steps of:
providing a catheter having a distal end, the catheter being slidably received by the arterial cannula; and moving the distal end of the catheter into the patient.
providing a catheter having a distal end, the catheter being slidably received by the arterial cannula; and moving the distal end of the catheter into the patient.
10. The method of claim 8, wherein:
the providing step is carried out with the catheter having a balloon.
the providing step is carried out with the catheter having a balloon.
11. The method of claim 8,wherein:
the providing step is carried out with the introduces having a cutting element, the cutting element having a retracted position and an extended position.
the providing step is carried out with the introduces having a cutting element, the cutting element having a retracted position and an extended position.
12. An arterial cannula assembly, comprising:
an elongate shaft having a first section, a second section, a proximal end and a distal end, the first section extending from the proximal end toward the second section and the second section extending from the first section to the distal end, the second section extending for a length of between 2-6 cm from the distal end, the first section and the second sections forming an angle therebetween of about 110 to 140 degrees:
a lumen passing through the elongate shaft, the blood flow lumen having an outlet.
an elongate shaft having a first section, a second section, a proximal end and a distal end, the first section extending from the proximal end toward the second section and the second section extending from the first section to the distal end, the second section extending for a length of between 2-6 cm from the distal end, the first section and the second sections forming an angle therebetween of about 110 to 140 degrees:
a lumen passing through the elongate shaft, the blood flow lumen having an outlet.
13. The arterial cannula assembly of claim 12, further comprising:
a stabilizing ring positioned around the second section of the elongate shaft, the stabilizing element forming an angle of 45 to 85 degrees with respect the second section.
a stabilizing ring positioned around the second section of the elongate shaft, the stabilizing element forming an angle of 45 to 85 degrees with respect the second section.
14. The arterial cannula assembly of claim 12, further comprising:
an introduces removably positioned in the blood flow lumen, the introduces extending beyond the distal end of the elongate shaft when positioned in the blood flow lumen.
an introduces removably positioned in the blood flow lumen, the introduces extending beyond the distal end of the elongate shaft when positioned in the blood flow lumen.
15. The arterial cannula assembly of claim 12, wherein:
the introduces has a cutting element which is movable from an extended 3 position to a retracted position, the cutting element extending beyond a distal end of the introduces when in the extended position.
the introduces has a cutting element which is movable from an extended 3 position to a retracted position, the cutting element extending beyond a distal end of the introduces when in the extended position.
16. The arterial cannula assembly of claim 12, further comprising:
a y-arm connector coupled to the proximal end of the elongate shaft, the y-arm connector having a first arm and a second arm, the first arm being fluidly coupled to the blood flow lumen, the second arm having a hemostasis valve for receiving a catheter.
a y-arm connector coupled to the proximal end of the elongate shaft, the y-arm connector having a first arm and a second arm, the first arm being fluidly coupled to the blood flow lumen, the second arm having a hemostasis valve for receiving a catheter.
17. The arterial cannula assembly of claim 16, further comprising:
an aortic occlusion catheter received by the second arm of the y-arm connector, the aortic occlusion catheter having an occluding member movable from a collapsed shape to an expanded shape.
an aortic occlusion catheter received by the second arm of the y-arm connector, the aortic occlusion catheter having an occluding member movable from a collapsed shape to an expanded shape.
18. An aortic occlusion device for occluding a patient's aorta, comprising:
an elongate shaft having a longitudinal axis;
a lumen passing through the shaft;
a balloon attached to the shaft, the balloon having a first section and a second section, the first section extending around a shorter portion of the longitudinal axis than the second section, the first and second secaions being continuous and being fluidly coupled together.
an elongate shaft having a longitudinal axis;
a lumen passing through the shaft;
a balloon attached to the shaft, the balloon having a first section and a second section, the first section extending around a shorter portion of the longitudinal axis than the second section, the first and second secaions being continuous and being fluidly coupled together.
19. The aortic occlusion device of claim E, further comprising:
a second lumen passing through the shaft.
a second lumen passing through the shaft.
20. The aortic occlusion device of claim E, further comprising:
a venting catheter extending through they second lumen in the shaft.
a venting catheter extending through they second lumen in the shaft.
1. A method of stabilizing an occluding member in a patient comprising the steps of:
introducing an occluding member into a patient, the occluding member being movable from a collapsed shape to an expanded shape, the occluding member being introduced into the patient in the collapsed shape;
positioning an expandable stabilizing structure adjacent the occluding member, the stabilizing structure having at least one opening which permits flow of fluids therethrough;
expanding the expandable structure after the positioning step so that t;
expanding the occluding member, the occluding member being stabilized by the stabilizing structure to prevent flipping of the occluding member in the patient.
introducing an occluding member into a patient, the occluding member being movable from a collapsed shape to an expanded shape, the occluding member being introduced into the patient in the collapsed shape;
positioning an expandable stabilizing structure adjacent the occluding member, the stabilizing structure having at least one opening which permits flow of fluids therethrough;
expanding the expandable structure after the positioning step so that t;
expanding the occluding member, the occluding member being stabilized by the stabilizing structure to prevent flipping of the occluding member in the patient.
22. The method of claim F, wherein:
the introducing step is carried out with the occluding member being mounted to a catheter having a lumen; and the positioning step is carried out with the stabilizing structure passing through the lumen in the catheter.
the introducing step is carried out with the occluding member being mounted to a catheter having a lumen; and the positioning step is carried out with the stabilizing structure passing through the lumen in the catheter.
23. A method of stabilizing an aortic occlusion member in a patient's ascending aorta, comprising the steps of:
providing an aortic occlusion member and a stabilizing structure, the aortic occlusion member being movable from a collapsed shape to an expanded shape, the stabilizing structure also being movable from a collapsed shape to an expanded shape, the stabilizing structure permitting blood flow therethrough when in the expanded shape;
introducing the aortic occlusion member into the patient:
positioning the aortic occlusion member in the ascending aorta:
expanding the aortic occlusion member; and expanding the stabilizing structure, the stabilizing structure being positioned adjacent the occlusion member to prevent distortion of the occlusion member.
providing an aortic occlusion member and a stabilizing structure, the aortic occlusion member being movable from a collapsed shape to an expanded shape, the stabilizing structure also being movable from a collapsed shape to an expanded shape, the stabilizing structure permitting blood flow therethrough when in the expanded shape;
introducing the aortic occlusion member into the patient:
positioning the aortic occlusion member in the ascending aorta:
expanding the aortic occlusion member; and expanding the stabilizing structure, the stabilizing structure being positioned adjacent the occlusion member to prevent distortion of the occlusion member.
24. The method of claim 23, wherein:
the providing step is carried out with the stabilizing structure being carried by a catheter and the aortic occlusion member is carried by a cannula, the cannula having a lumen which receives the catheter.
the providing step is carried out with the stabilizing structure being carried by a catheter and the aortic occlusion member is carried by a cannula, the cannula having a lumen which receives the catheter.
25. The method of claim 23, wherein:
the providing step is carried out with the stabilizing structure being a mesh basket.
the providing step is carried out with the stabilizing structure being a mesh basket.
26. The method of claim 23, wherein:
the stabilizer expanding step is carried out with the stabilizer being expanded downstream from the occluding member relative to the direction of natural blood.
the stabilizer expanding step is carried out with the stabilizer being expanded downstream from the occluding member relative to the direction of natural blood.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/012,833 | 1998-01-23 | ||
US09/012,833 US6159178A (en) | 1998-01-23 | 1998-01-23 | Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested |
PCT/US1999/001340 WO1999037202A2 (en) | 1998-01-23 | 1999-01-22 | Methods and devices for occluding the ascending aorta |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2284752A1 true CA2284752A1 (en) | 1999-07-29 |
Family
ID=21756932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002284752A Abandoned CA2284752A1 (en) | 1998-01-23 | 1999-01-22 | Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested |
Country Status (8)
Country | Link |
---|---|
US (7) | US6159178A (en) |
EP (2) | EP1413326A3 (en) |
AT (1) | ATE290814T1 (en) |
AU (1) | AU752773B2 (en) |
CA (1) | CA2284752A1 (en) |
DE (1) | DE69924198T2 (en) |
ES (1) | ES2241259T3 (en) |
WO (1) | WO1999037202A2 (en) |
Families Citing this family (182)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6287322B1 (en) * | 1995-12-07 | 2001-09-11 | Loma Linda University Medical Center | Tissue opening locator and everter and method |
US20020019642A1 (en) * | 1996-07-23 | 2002-02-14 | Keith Milliman | Anastomosis instrument and method for performing same |
US6440146B2 (en) | 1996-07-23 | 2002-08-27 | United States Surgical Corporation | Anastomosis instrument and method |
US7223273B2 (en) * | 1996-07-23 | 2007-05-29 | Tyco Healthcare Group Lp | Anastomosis instrument and method for performing same |
US6159178A (en) * | 1998-01-23 | 2000-12-12 | Heartport, Inc. | Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested |
US6295990B1 (en) * | 1998-02-03 | 2001-10-02 | Salient Interventional Systems, Inc. | Methods and systems for treating ischemia |
US20030153976A1 (en) * | 1999-10-20 | 2003-08-14 | Cauthen Joseph C. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
ES2281407T3 (en) * | 2000-01-18 | 2007-10-01 | Tyco Healthcare Group Lp | INSTRUMENT FOR ANASTOMOSIS. |
US6488693B2 (en) * | 2000-01-26 | 2002-12-03 | Hearport, Inc. | Vascular incisor and method |
DE60143022D1 (en) * | 2000-02-24 | 2010-10-21 | Univ Loma Linda Med | GLUE PLASTER AND DISPOSAL SYSTEM FOR CLOSING A TISSUE OPENING DURING SURGICAL TREATMENT |
US6645160B1 (en) * | 2000-03-17 | 2003-11-11 | Christian M. Heesch | Guide support catheter |
US7815649B2 (en) * | 2000-04-07 | 2010-10-19 | Kyphon SÀRL | Insertion devices and method of use |
US8092480B2 (en) * | 2000-04-07 | 2012-01-10 | Kyphon Sarl | Platform cannula for guiding the expansion of expandable bodies and method of use |
US6746426B1 (en) * | 2000-07-11 | 2004-06-08 | Medtronic Vascular, Inc. | Transluminally deliverable vascular blockers and methods for facilitating retrograde flow of arterial blood through veins |
US6890342B2 (en) | 2000-08-02 | 2005-05-10 | Loma Linda University | Method and apparatus for closing vascular puncture using hemostatic material |
US8323228B2 (en) * | 2007-04-12 | 2012-12-04 | Rex Medical L.P. | Dialysis catheter |
US6858019B2 (en) * | 2001-01-09 | 2005-02-22 | Rex Medical, L.P. | Dialysis catheter and methods of insertion |
EP1351612B1 (en) * | 2001-01-12 | 2007-10-03 | Napoli, LLC | Intra-uterine microcatheter |
US20060183973A1 (en) * | 2001-01-12 | 2006-08-17 | Kamrava Michael M | Endoscopic devices and method of use |
US7285097B2 (en) * | 2001-01-12 | 2007-10-23 | Radi Medical System Ab | Technique to confirm correct positioning with respect to arterial wall |
US8465412B2 (en) * | 2001-01-12 | 2013-06-18 | Michael Levy | Uterine devices and method of use |
WO2002056955A1 (en) * | 2001-01-18 | 2002-07-25 | Edwards Lifesciences Corporation | Arterial cannula with perforated filter lumen |
ES2307723T3 (en) * | 2001-01-24 | 2008-12-01 | Tyco Healthcare Group Lp | INSTRUMENT FOR ANASTOMOSIS AND METHOD TO CARRY IT OUT. |
DE10105592A1 (en) | 2001-02-06 | 2002-08-08 | Achim Goepferich | Placeholder for drug release in the frontal sinus |
US6783511B2 (en) * | 2001-04-12 | 2004-08-31 | Heartport, Inc. | Methods and devices for occluding a patient's ascending aorta and delivering oxygenated blood to the patient |
EP1283025A1 (en) * | 2001-08-10 | 2003-02-12 | Stöckert Instrumente GmbH | Ballon occlusion device |
US7892273B2 (en) * | 2001-12-03 | 2011-02-22 | Xtent, Inc. | Custom length stent apparatus |
US7137993B2 (en) | 2001-12-03 | 2006-11-21 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US20040186551A1 (en) | 2003-01-17 | 2004-09-23 | Xtent, Inc. | Multiple independent nested stent structures and methods for their preparation and deployment |
US7351255B2 (en) | 2001-12-03 | 2008-04-01 | Xtent, Inc. | Stent delivery apparatus and method |
US7147656B2 (en) * | 2001-12-03 | 2006-12-12 | Xtent, Inc. | Apparatus and methods for delivery of braided prostheses |
AUPR969701A0 (en) * | 2001-12-20 | 2002-01-24 | Petros, Peter Emmanuel Dr | Surgical instrument |
AU2003215342A1 (en) | 2002-02-21 | 2003-09-09 | Design Mentor, Inc. | Fluid pump |
US6769594B2 (en) * | 2002-05-31 | 2004-08-03 | Tyco Healthcare Group, Lp | End-to-end anastomosis instrument and method for performing same |
US7195142B2 (en) * | 2003-05-30 | 2007-03-27 | Tyco Healthcare Group Lp | End-to-end anastomosis instrument and method for performing same |
AU2003276105A1 (en) | 2002-06-14 | 2003-12-31 | Loma Linda University Medical Center | Vascular wound closure device and method |
US20040010274A1 (en) * | 2002-07-10 | 2004-01-15 | Manzo Scott E. | Anastomosis instrument and method for performing same |
US8317816B2 (en) | 2002-09-30 | 2012-11-27 | Acclarent, Inc. | Balloon catheters and methods for treating paranasal sinuses |
US6849061B2 (en) * | 2002-10-21 | 2005-02-01 | Robert B. Wagner | Method and apparatus for pleural drainage |
WO2005002648A2 (en) * | 2003-06-24 | 2005-01-13 | Cook Critical Care Incorporated | Catheter for extracorporeal treatment |
US20050010241A1 (en) * | 2003-07-09 | 2005-01-13 | Keith Milliman | Anastomosis instrument and method for performing same |
JP4599353B2 (en) * | 2003-07-17 | 2010-12-15 | コラゾン テクノロジーズ インコーポレーティッド | Device for percutaneously treating aortic stenosis |
EP2345371B1 (en) | 2003-08-14 | 2014-07-16 | Loma Linda University Medical Center | Vascular wound closure device |
US8187627B2 (en) | 2003-09-05 | 2012-05-29 | Loma Linda University Medical Center | Dressing delivery system for internal wounds |
US20050113693A1 (en) * | 2003-10-03 | 2005-05-26 | Smith Stephen W. | Kits including 3-D ultrasound imaging catheters, connectable deployable tools, and deployment devices for use in deployment of such tools |
US20050075720A1 (en) | 2003-10-06 | 2005-04-07 | Nguyen Tuoc Tan | Minimally invasive valve replacement system |
US7553324B2 (en) * | 2003-10-14 | 2009-06-30 | Xtent, Inc. | Fixed stent delivery devices and methods |
US20070156225A1 (en) * | 2003-12-23 | 2007-07-05 | Xtent, Inc. | Automated control mechanisms and methods for custom length stent apparatus |
US7326236B2 (en) | 2003-12-23 | 2008-02-05 | Xtent, Inc. | Devices and methods for controlling and indicating the length of an interventional element |
US9232948B2 (en) * | 2003-12-23 | 2016-01-12 | Stryker Corporation | Catheter with distal occlusion apparatus |
WO2005067999A2 (en) * | 2004-01-13 | 2005-07-28 | Centripeta Limited | Device for fluid delivery to an enclosed space |
US8764725B2 (en) * | 2004-02-09 | 2014-07-01 | Covidien Lp | Directional anchoring mechanism, method and applications thereof |
US7998129B2 (en) * | 2004-03-11 | 2011-08-16 | The Trustees Of The University Of Pennsylvainia | Device for facilitating cardioplegia delivery in patients with aortic insufficiency |
US8100822B2 (en) | 2004-03-16 | 2012-01-24 | Macroplata Systems, Llc | Anoscope for treating hemorrhoids without the trauma of cutting or the use of an endoscope |
US7323006B2 (en) * | 2004-03-30 | 2008-01-29 | Xtent, Inc. | Rapid exchange interventional devices and methods |
US8747389B2 (en) | 2004-04-21 | 2014-06-10 | Acclarent, Inc. | Systems for treating disorders of the ear, nose and throat |
US10188413B1 (en) | 2004-04-21 | 2019-01-29 | Acclarent, Inc. | Deflectable guide catheters and related methods |
US20070167682A1 (en) | 2004-04-21 | 2007-07-19 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
US7559925B2 (en) | 2006-09-15 | 2009-07-14 | Acclarent Inc. | Methods and devices for facilitating visualization in a surgical environment |
US7654997B2 (en) | 2004-04-21 | 2010-02-02 | Acclarent, Inc. | Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat |
US20190314620A1 (en) | 2004-04-21 | 2019-10-17 | Acclarent, Inc. | Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures |
US9101384B2 (en) | 2004-04-21 | 2015-08-11 | Acclarent, Inc. | Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, Nose and/or throat |
US8146400B2 (en) | 2004-04-21 | 2012-04-03 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
US9554691B2 (en) | 2004-04-21 | 2017-01-31 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
US8894614B2 (en) | 2004-04-21 | 2014-11-25 | Acclarent, Inc. | Devices, systems and methods useable for treating frontal sinusitis |
US20060004323A1 (en) | 2004-04-21 | 2006-01-05 | Exploramed Nc1, Inc. | Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures |
US20060063973A1 (en) | 2004-04-21 | 2006-03-23 | Acclarent, Inc. | Methods and apparatus for treating disorders of the ear, nose and throat |
US9399121B2 (en) | 2004-04-21 | 2016-07-26 | Acclarent, Inc. | Systems and methods for transnasal dilation of passageways in the ear, nose or throat |
US9351750B2 (en) | 2004-04-21 | 2016-05-31 | Acclarent, Inc. | Devices and methods for treating maxillary sinus disease |
US8764729B2 (en) | 2004-04-21 | 2014-07-01 | Acclarent, Inc. | Frontal sinus spacer |
US20070208252A1 (en) | 2004-04-21 | 2007-09-06 | Acclarent, Inc. | Systems and methods for performing image guided procedures within the ear, nose, throat and paranasal sinuses |
US7803150B2 (en) | 2004-04-21 | 2010-09-28 | Acclarent, Inc. | Devices, systems and methods useable for treating sinusitis |
US8932276B1 (en) | 2004-04-21 | 2015-01-13 | Acclarent, Inc. | Shapeable guide catheters and related methods |
US7462175B2 (en) | 2004-04-21 | 2008-12-09 | Acclarent, Inc. | Devices, systems and methods for treating disorders of the ear, nose and throat |
US9089258B2 (en) | 2004-04-21 | 2015-07-28 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
US7410480B2 (en) | 2004-04-21 | 2008-08-12 | Acclarent, Inc. | Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders |
US7419497B2 (en) | 2004-04-21 | 2008-09-02 | Acclarent, Inc. | Methods for treating ethmoid disease |
US8702626B1 (en) | 2004-04-21 | 2014-04-22 | Acclarent, Inc. | Guidewires for performing image guided procedures |
US7361168B2 (en) | 2004-04-21 | 2008-04-22 | Acclarent, Inc. | Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders |
US20050240278A1 (en) * | 2004-04-26 | 2005-10-27 | Peter Aliski | Stent improvements |
US7507218B2 (en) * | 2004-04-26 | 2009-03-24 | Gyrus Acmi, Inc. | Stent with flexible elements |
US7470247B2 (en) * | 2004-04-26 | 2008-12-30 | Gyrus Acmi, Inc. | Ureteral stent |
US20050240141A1 (en) * | 2004-04-26 | 2005-10-27 | Peter Aliski | Stent kidney curl improvements |
WO2005110026A2 (en) | 2004-05-07 | 2005-11-24 | Emory University | Cardioplegia catheter system |
US20050288766A1 (en) * | 2004-06-28 | 2005-12-29 | Xtent, Inc. | Devices and methods for controlling expandable prostheses during deployment |
US8317859B2 (en) | 2004-06-28 | 2012-11-27 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US7811300B2 (en) * | 2004-09-17 | 2010-10-12 | Codman & Shurtleff, Inc. | Thin film devices for temporary or permanent occlusion of a vessel |
US9216015B2 (en) | 2004-10-28 | 2015-12-22 | Vycor Medical, Inc. | Apparatus and methods for performing brain surgery |
US8882787B2 (en) * | 2005-03-02 | 2014-11-11 | St. Jude Medical, Cardiology Division, Inc. | Tissue anchor apparatus |
US7476232B2 (en) * | 2005-03-04 | 2009-01-13 | Boston Scientific Scimed, Inc. | Access catheter having dilation capability and related methods |
US8951225B2 (en) | 2005-06-10 | 2015-02-10 | Acclarent, Inc. | Catheters with non-removable guide members useable for treatment of sinusitis |
US20060287583A1 (en) | 2005-06-17 | 2006-12-21 | Pool Cover Corporation | Surgical access instruments for use with delicate tissues |
CA2550752C (en) * | 2005-06-28 | 2014-09-09 | Sherwood Services Ag | Illuminated ivs tunneling device |
US8257323B2 (en) * | 2005-08-03 | 2012-09-04 | Medtronic, Inc. | Cannula system and method |
US8114113B2 (en) | 2005-09-23 | 2012-02-14 | Acclarent, Inc. | Multi-conduit balloon catheter |
US8029494B2 (en) * | 2005-10-24 | 2011-10-04 | Cook Medical Technologies Llc | Method of removing biliary stones with coaxial catheter device |
US8163002B2 (en) * | 2005-11-14 | 2012-04-24 | Vascular Devices Llc | Self-sealing vascular graft |
US20070142850A1 (en) * | 2005-12-15 | 2007-06-21 | David Fowler | Compression anastomosis device |
US20070179602A1 (en) * | 2006-01-27 | 2007-08-02 | Genesee Biomedical, Inc. | Method and Devices For Cardiac Valve Annulus Expansion |
US20070225750A1 (en) * | 2006-03-10 | 2007-09-27 | Brooke Ren | Embolic protection systems |
AU2007227000A1 (en) * | 2006-03-20 | 2007-09-27 | Xtent, Inc. | Apparatus and methods for deployment of linked prosthetic segments |
US8190389B2 (en) | 2006-05-17 | 2012-05-29 | Acclarent, Inc. | Adapter for attaching electromagnetic image guidance components to a medical device |
JP5095124B2 (en) * | 2006-05-17 | 2012-12-12 | 富士フイルム株式会社 | Endoscope |
US20070281117A1 (en) * | 2006-06-02 | 2007-12-06 | Xtent, Inc. | Use of plasma in formation of biodegradable stent coating |
US9820688B2 (en) | 2006-09-15 | 2017-11-21 | Acclarent, Inc. | Sinus illumination lightwire device |
US7637907B2 (en) * | 2006-09-19 | 2009-12-29 | Covidien Ag | System and method for return electrode monitoring |
US8795288B2 (en) * | 2006-11-02 | 2014-08-05 | Cook Medical Technologies Llc | Access device |
US8439687B1 (en) | 2006-12-29 | 2013-05-14 | Acclarent, Inc. | Apparatus and method for simulated insertion and positioning of guidewares and other interventional devices |
US20080199510A1 (en) | 2007-02-20 | 2008-08-21 | Xtent, Inc. | Thermo-mechanically controlled implants and methods of use |
US8486132B2 (en) | 2007-03-22 | 2013-07-16 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
WO2008124787A2 (en) | 2007-04-09 | 2008-10-16 | Acclarent, Inc. | Ethmoidotomy system and implantable spacer devices having therapeutic substance delivery capability for treatment of paranasal sinusitis |
US8118757B2 (en) | 2007-04-30 | 2012-02-21 | Acclarent, Inc. | Methods and devices for ostium measurement |
US8485199B2 (en) | 2007-05-08 | 2013-07-16 | Acclarent, Inc. | Methods and devices for protecting nasal turbinate during surgery |
ES2913223T3 (en) | 2007-07-18 | 2022-06-01 | Silk Road Medical Inc | Systems for establishing retrograde carotid arterial blood flow |
US8858490B2 (en) | 2007-07-18 | 2014-10-14 | Silk Road Medical, Inc. | Systems and methods for treating a carotid artery |
US8002729B2 (en) | 2007-08-21 | 2011-08-23 | Cook Medical Technologies Llc | Multi-lumen catheter assembly |
US7719869B2 (en) * | 2007-11-19 | 2010-05-18 | Qimonda Ag | Memory cell array comprising floating body memory cells |
US10206821B2 (en) | 2007-12-20 | 2019-02-19 | Acclarent, Inc. | Eustachian tube dilation balloon with ventilation path |
WO2009099764A1 (en) * | 2008-02-05 | 2009-08-13 | Silk Road Medical, Inc. | Interventional sheath with retention features |
US9101503B2 (en) | 2008-03-06 | 2015-08-11 | J.W. Medical Systems Ltd. | Apparatus having variable strut length and methods of use |
US8182432B2 (en) | 2008-03-10 | 2012-05-22 | Acclarent, Inc. | Corewire design and construction for medical devices |
US8858528B2 (en) | 2008-04-23 | 2014-10-14 | Ncontact Surgical, Inc. | Articulating cannula access device |
US8939991B2 (en) * | 2008-06-08 | 2015-01-27 | Hotspur Technologies, Inc. | Apparatus and methods for removing obstructive material from body lumens |
US8267951B2 (en) | 2008-06-12 | 2012-09-18 | Ncontact Surgical, Inc. | Dissecting cannula and methods of use thereof |
US8945160B2 (en) | 2008-07-03 | 2015-02-03 | Hotspur Technologies, Inc. | Apparatus and methods for treating obstructions within body lumens |
US9101382B2 (en) | 2009-02-18 | 2015-08-11 | Hotspur Technologies, Inc. | Apparatus and methods for treating obstructions within body lumens |
US8043313B2 (en) | 2008-07-03 | 2011-10-25 | Hotspur Technologies, Inc | Apparatus and methods for treating obstructions within body lumens |
EP2306886B1 (en) | 2008-07-30 | 2018-10-31 | Acclarent, Inc. | Paranasal ostium finder devices |
WO2010033629A1 (en) | 2008-09-18 | 2010-03-25 | Acclarent, Inc. | Methods and apparatus for treating disorders of the ear nose and throat |
US20100145285A1 (en) * | 2008-12-09 | 2010-06-10 | Cook Critical Care, Incorporated | Multi-lumen catheter configuration |
US20170202657A1 (en) | 2009-01-16 | 2017-07-20 | Claret Medical, Inc. | Intravascular blood filters and methods of use |
US9636205B2 (en) | 2009-01-16 | 2017-05-02 | Claret Medical, Inc. | Intravascular blood filters and methods of use |
ES2516066T3 (en) | 2009-01-16 | 2014-10-30 | Claret Medical, Inc. | Intravascular blood filter |
US9326843B2 (en) | 2009-01-16 | 2016-05-03 | Claret Medical, Inc. | Intravascular blood filters and methods of use |
US8518073B2 (en) * | 2009-01-29 | 2013-08-27 | Claret Medical, Inc. | Illuminated intravascular blood filter |
US20120109057A1 (en) | 2009-02-18 | 2012-05-03 | Hotspur Technologies, Inc. | Apparatus and methods for treating obstructions within body lumens |
US20100241155A1 (en) | 2009-03-20 | 2010-09-23 | Acclarent, Inc. | Guide system with suction |
US8435290B2 (en) | 2009-03-31 | 2013-05-07 | Acclarent, Inc. | System and method for treatment of non-ventilating middle ear by providing a gas pathway through the nasopharynx |
US7978742B1 (en) | 2010-03-24 | 2011-07-12 | Corning Incorporated | Methods for operating diode lasers |
JP5254125B2 (en) * | 2009-05-11 | 2013-08-07 | 富士フイルム株式会社 | Internal pressure detecting device and endoscope device for expansion / contraction member |
US8974489B2 (en) | 2009-07-27 | 2015-03-10 | Claret Medical, Inc. | Dual endovascular filter and methods of use |
US20110071490A1 (en) * | 2009-09-18 | 2011-03-24 | Kassab Interventional Devices, Llc ("Kids") | System and procedure for placing a medical device proximate an ostial lesion using a catheter assembly |
US8413872B2 (en) * | 2009-10-28 | 2013-04-09 | Covidien Lp | Surgical fastening apparatus |
US8496607B2 (en) | 2009-12-04 | 2013-07-30 | Cook Medical Technologies Llc | Multi-lumen catheter |
US11344285B2 (en) | 2009-12-16 | 2022-05-31 | Boston Scientific Scimed, Inc. | Multi-lumen-catheter retractor system for a minimally-invasive, operative gastrointestinal treatment |
US9565998B2 (en) | 2009-12-16 | 2017-02-14 | Boston Scientific Scimed, Inc. | Multi-lumen-catheter retractor system for a minimally-invasive, operative gastrointestinal treatment |
US8932211B2 (en) | 2012-06-22 | 2015-01-13 | Macroplata, Inc. | Floating, multi-lumen-catheter retractor system for a minimally-invasive, operative gastrointestinal treatment |
US10531869B2 (en) | 2009-12-16 | 2020-01-14 | Boston Scientific Scimed, Inc. | Tissue retractor for minimally invasive surgery |
US10758116B2 (en) | 2009-12-16 | 2020-09-01 | Boston Scientific Scimed, Inc. | System for a minimally-invasive, operative gastrointestinal treatment |
USRE48850E1 (en) | 2009-12-16 | 2021-12-14 | Boston Scientific Scimed, Inc. | Multi-lumen-catheter retractor system for a minimally-invasive, operative gastrointestinal treatment |
US10595711B2 (en) | 2009-12-16 | 2020-03-24 | Boston Scientific Scimed, Inc. | System for a minimally-invasive, operative gastrointestinal treatment |
US10966701B2 (en) | 2009-12-16 | 2021-04-06 | Boston Scientific Scimed, Inc. | Tissue retractor for minimally invasive surgery |
US8506479B2 (en) | 2009-12-16 | 2013-08-13 | Macroplata, Inc. | Substantially rigid and stable endoluminal surgical suite for treating a gastrointestinal lesion |
US9220872B2 (en) * | 2010-04-13 | 2015-12-29 | Sundaram Ravikumar | Bidirectional vascular introducer sheath |
US8591450B2 (en) | 2010-06-07 | 2013-11-26 | Rex Medical L.P. | Dialysis catheter |
FR2961683B1 (en) | 2010-06-23 | 2013-11-29 | Assist Publ Hopitaux De Paris | CANNULA FOR REALIZING REGIONAL EXTRACORPOREAL CIRCULATION |
US9155492B2 (en) | 2010-09-24 | 2015-10-13 | Acclarent, Inc. | Sinus illumination lightwire device |
US9017364B2 (en) | 2010-12-30 | 2015-04-28 | Claret Medical, Inc. | Deflectable intravascular filter |
CN103619274A (en) * | 2011-05-02 | 2014-03-05 | 美敦力 | Compliant sleeves coupled with wire structures for cryoablation |
US9039661B2 (en) * | 2011-05-24 | 2015-05-26 | Fresenius Kabi Deutschland Gmbh | Tube for the enteral feeding of a patient |
US9168352B2 (en) | 2011-12-19 | 2015-10-27 | Cardiacassist, Inc. | Dual lumen cannula |
US10661056B1 (en) | 2012-02-24 | 2020-05-26 | Christian M. Heesch | Guide catheter support instrument |
US9126013B2 (en) | 2012-04-27 | 2015-09-08 | Teleflex Medical Incorporated | Catheter with adjustable guidewire exit position |
EP2879750B1 (en) * | 2012-08-03 | 2019-04-17 | National University of Singapore | Arterial cannula which allows perfusion along opposing directions within a cannulated vessel |
US9433437B2 (en) | 2013-03-15 | 2016-09-06 | Acclarent, Inc. | Apparatus and method for treatment of ethmoid sinusitis |
US9629684B2 (en) | 2013-03-15 | 2017-04-25 | Acclarent, Inc. | Apparatus and method for treatment of ethmoid sinusitis |
WO2015116004A1 (en) * | 2014-01-30 | 2015-08-06 | Singapore Health Services Pte Ltd | Arterial sheath which allows distal perfusion within a cannulated vessel |
US9737287B2 (en) | 2014-05-13 | 2017-08-22 | Vycor Medical, Inc. | Guidance system mounts for surgical introducers |
US9795366B2 (en) | 2014-09-18 | 2017-10-24 | Edwards Lifesciences Corporation | Bio-absorbable wound closure device and method |
US9566144B2 (en) | 2015-04-22 | 2017-02-14 | Claret Medical, Inc. | Vascular filters, deflectors, and methods |
US10525179B2 (en) | 2016-03-31 | 2020-01-07 | Heartware, Inc. | Crenellated inflow cannula |
US10543016B2 (en) | 2016-11-07 | 2020-01-28 | Vycor Medical, Inc. | Surgical introducer with guidance system receptacle |
US10376258B2 (en) | 2016-11-07 | 2019-08-13 | Vycor Medical, Inc. | Surgical introducer with guidance system receptacle |
EP3585304B1 (en) | 2017-02-22 | 2022-04-27 | Boston Scientific Scimed, Inc. | Systems for protecting the cerebral vasculature |
CN111565673A (en) | 2017-10-27 | 2020-08-21 | 波士顿科学医学有限公司 | System and method for protecting cerebral blood vessels |
US11154390B2 (en) | 2017-12-19 | 2021-10-26 | Claret Medical, Inc. | Systems for protection of the cerebral vasculature during a cardiac procedure |
JP7093849B2 (en) | 2018-04-26 | 2022-06-30 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Systems and methods to protect the cerebrovascular system |
EP3840691A1 (en) | 2018-08-21 | 2021-06-30 | Boston Scientific Scimed, Inc. | Systems for protecting the cerebral vasculature |
US11439144B2 (en) * | 2018-11-27 | 2022-09-13 | Gift Of Hope Organ & Tissue Donor Network | Apparatus and methods for delivering cold perfusion fluids in organ donors |
IT201900007070A1 (en) * | 2019-05-21 | 2020-11-21 | Marco Gennari | BLOOD PERFUSION MEDICAL DEVICE |
US11832789B2 (en) | 2019-12-13 | 2023-12-05 | Boston Scientific Scimed, Inc. | Devices, systems, and methods for minimally invasive surgery in a body lumen |
US11464947B1 (en) * | 2021-12-30 | 2022-10-11 | Kok Hoo LIM | Aortic perfusion catheter |
Family Cites Families (295)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US504424A (en) | 1893-09-05 | Oscar de pezzer | ||
US33258A (en) * | 1861-09-10 | Improvement in gas-burners | ||
US1271456A (en) * | 1917-12-03 | 1918-07-02 | Theodore J Flack | Rectal dilator. |
US2308484A (en) * | 1939-01-16 | 1943-01-19 | Davol Rubber Co | Catheter |
US2854982A (en) * | 1958-01-22 | 1958-10-07 | Vito V Pagano | Nasopharyngeal tube |
US3108595A (en) | 1960-08-08 | 1963-10-29 | Alfred P Overment | Retention catheter |
US3435826A (en) | 1964-05-27 | 1969-04-01 | Edwards Lab Inc | Embolectomy catheter |
US3334629A (en) * | 1964-11-09 | 1967-08-08 | Bertram D Cohn | Occlusive device for inferior vena cava |
US3385300A (en) * | 1965-08-10 | 1968-05-28 | Holter Company | Cervical cannula |
US3397699A (en) | 1966-05-05 | 1968-08-20 | Gerald C. Kohl | Retaining catheter having resiliently biased wing flanges |
US3557794A (en) | 1968-07-30 | 1971-01-26 | Us Air Force | Arterial dilation device |
US3568659A (en) | 1968-09-24 | 1971-03-09 | James N Karnegis | Disposable percutaneous intracardiac pump and method of pumping blood |
SE336642B (en) * | 1969-10-28 | 1971-07-12 | Astra Meditec Ab | |
US3635223A (en) * | 1969-12-02 | 1972-01-18 | Us Catheter & Instr Corp | Embolectomy catheter |
US3692018A (en) * | 1970-02-11 | 1972-09-19 | Robert H Goetz | Cardiac assistance device |
US3634924A (en) | 1970-04-20 | 1972-01-18 | American Hospital Supply Corp | Method of making multilumen balloon catheter |
GB1340788A (en) * | 1971-02-04 | 1974-01-30 | Matburn Holdings Ltd | Nasal tampons |
US3788328A (en) * | 1971-04-29 | 1974-01-29 | Sherwood Medical Ind Inc | Cardiovascular catheter |
GB1402255A (en) | 1971-09-24 | 1975-08-06 | Smiths Industries Ltd | Medical or surgical devices of the kind having an inflatable balloon |
US3769960A (en) * | 1972-04-17 | 1973-11-06 | Us Health Education & Welfare | Intra-aortic balloon system |
US3837347A (en) * | 1972-04-20 | 1974-09-24 | Electro Catheter Corp | Inflatable balloon-type pacing probe |
AU5722173A (en) * | 1972-07-04 | 1975-01-09 | Stanley Francis Duturbure | Catheter tube |
US3833003A (en) * | 1972-07-05 | 1974-09-03 | A Taricco | Intravascular occluding catheter |
US3799172A (en) | 1972-09-25 | 1974-03-26 | R Szpur | Retention catheter |
US3903895A (en) * | 1973-01-05 | 1975-09-09 | Sherwood Medical Ind Inc | Cardiovascular catheter |
US3851647A (en) * | 1973-03-07 | 1974-12-03 | Bard Inc C R | Intravenous catheter introduction assembly |
US3812860A (en) | 1973-04-05 | 1974-05-28 | Int Paper Co | Retention catheter |
US3734100A (en) | 1973-05-07 | 1973-05-22 | Medical Products Corp | Catheter tubes |
US3865666A (en) | 1973-05-08 | 1975-02-11 | Int Paper Co | Method of making a catheter |
US3915171A (en) * | 1974-06-06 | 1975-10-28 | Dennis William Shermeta | Gastrostomy tube |
US3983879A (en) * | 1974-07-25 | 1976-10-05 | Western Acadia, Incorporated | Silicone catheter |
US3959429A (en) | 1975-02-03 | 1976-05-25 | International Paper Company | Method of making a retention catheter and molding a tip thereon |
US3970090A (en) * | 1975-02-03 | 1976-07-20 | Physio Medics, Inc. | Catheter |
US3963028A (en) * | 1975-02-06 | 1976-06-15 | Texas Medical Products, Inc. | Suction wand |
US4000739A (en) * | 1975-07-09 | 1977-01-04 | Cordis Corporation | Hemostasis cannula |
US4019515A (en) * | 1975-12-08 | 1977-04-26 | Daniel Kornblum | Enemata administering device |
US4073297A (en) * | 1976-02-11 | 1978-02-14 | Sandoz Ltd. | Catheter |
US4029104A (en) * | 1976-03-08 | 1977-06-14 | Kerber Charles W | Calibrated leak balloon micro-catheter |
US4122858A (en) * | 1977-03-23 | 1978-10-31 | Peter Schiff | Adapter for intra-aortic balloons and the like |
US4173981A (en) * | 1977-05-23 | 1979-11-13 | University Of Utah | Cannula for arterial and venous bypass cannulation |
US4284073A (en) * | 1977-10-11 | 1981-08-18 | Krause Horst E | Method and apparatus for pumping blood within a vessel |
US4154227A (en) * | 1977-10-11 | 1979-05-15 | Krause Horst E | Method and apparatus for pumping blood within a vessel |
US4204328A (en) * | 1977-11-14 | 1980-05-27 | Kutner Barry S | Variable diameter aspirating tip |
US4327709A (en) * | 1978-03-06 | 1982-05-04 | Datascope Corp. | Apparatus and method for the percutaneous introduction of intra-aortic balloons into the human body |
US4323071A (en) * | 1978-04-24 | 1982-04-06 | Advanced Catheter Systems, Inc. | Vascular guiding catheter assembly and vascular dilating catheter assembly and a combination thereof and methods of making the same |
US4248224A (en) * | 1978-08-01 | 1981-02-03 | Jones James W | Double venous cannula |
FR2434628A1 (en) * | 1978-09-01 | 1980-03-28 | Durand Alain | BALLOON CATHETER |
US4301803A (en) * | 1978-10-06 | 1981-11-24 | Kuraray Co., Ltd. | Balloon catheter |
US4276874A (en) * | 1978-11-15 | 1981-07-07 | Datascope Corp. | Elongatable balloon catheter |
US4285341A (en) * | 1978-11-22 | 1981-08-25 | Pollack Charles N | Extracorporeal cannula apparatus with retractable intralumenal balloon and method for using same |
US4493697A (en) * | 1979-05-10 | 1985-01-15 | Krause Horst E | Method and apparatus for pumping blood within a vessel |
US4289129A (en) * | 1979-11-01 | 1981-09-15 | Turner Roger S | Injection site apparatus |
US4310017A (en) * | 1980-01-30 | 1982-01-12 | Burron Medical Inc. | Backflow check valve for use with IV administration sets |
US4287892A (en) * | 1980-03-03 | 1981-09-08 | Peter Schiff | Cannula for intra-aortic balloon devices and the like |
US4304239A (en) * | 1980-03-07 | 1981-12-08 | The Kendall Company | Esophageal probe with balloon electrode |
US4686085A (en) * | 1980-04-14 | 1987-08-11 | Thomas Jefferson University | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
US4830849A (en) | 1980-04-14 | 1989-05-16 | Thomas Jefferson University | Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
US4411055A (en) * | 1980-05-19 | 1983-10-25 | Advanced Cardiovascular Systems, Inc. | Vascular guiding catheter assembly and vascular dilating catheter assembly and a combination thereof and methods for making the same |
US4328056A (en) * | 1980-07-09 | 1982-05-04 | Sherwood Medical Industries Inc. | Method of making a cuffed tube |
US4351341A (en) * | 1980-08-15 | 1982-09-28 | Uresil Company | Balloon catheter |
US4413989A (en) * | 1980-09-08 | 1983-11-08 | Angiomedics Corporation | Expandable occlusion apparatus |
US4430081A (en) * | 1981-01-06 | 1984-02-07 | Cook, Inc. | Hemostasis sheath |
US4531936A (en) * | 1981-01-29 | 1985-07-30 | Gordon Robert T | Device and method for the selective delivery of drugs to the myocardium |
FR2502499B1 (en) * | 1981-03-27 | 1987-01-23 | Farcot Jean Christian | APPARATUS FOR BLOOD RETROPERFUSION, IN PARTICULAR FOR THE TREATMENT OF INFARCTUS BY INJECTION OF ARTERIAL BLOOD INTO THE CORONARY SINUS |
US4456000A (en) * | 1981-08-17 | 1984-06-26 | Angiomedics Corporation | Expandable occlusion apparatus |
DE3138620A1 (en) * | 1981-09-29 | 1983-04-14 | Adolf Dr.med. Ing.(grad.) 3000 Hannover Kuhl | DILATION DEVICE |
DE3235974A1 (en) * | 1981-11-24 | 1983-06-01 | Volkmar Dipl.-Ing. Merkel (FH), 8520 Erlangen | DEVICE FOR REMOVAL OR FOR THE EXPANSION OF CONSTRAINTS IN BODY LIQUID LEADING VESSELS |
US4405313A (en) * | 1982-01-29 | 1983-09-20 | Sisley James R | Figure-eight, dual-lumen catheter and method of using |
US4417576A (en) * | 1982-02-25 | 1983-11-29 | Baran Ostap E | Double-wall surgical cuff |
US4451251A (en) * | 1982-03-03 | 1984-05-29 | Thomas Jefferson University | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
EP0102352A1 (en) * | 1982-03-12 | 1984-03-14 | WEBSTER, Wilton W.Jr. | Autoinflatable catheter |
US4497325A (en) * | 1982-07-15 | 1985-02-05 | Wedel Victor J | Ultrasound needle, biopsy instrument or catheter guide |
US4527549A (en) * | 1982-08-05 | 1985-07-09 | Shelhigh Inc. | Method of and means for intraaortic assist |
US4441495A (en) * | 1982-08-16 | 1984-04-10 | Becton, Dickinson And Company | Detachable balloon catheter device and method of use |
US4464175A (en) * | 1982-08-25 | 1984-08-07 | Altman Alan R | Multipurpose tamponade and thrombosclerotherapy tube |
US4496345A (en) * | 1982-08-30 | 1985-01-29 | Hasson Harrith M | Ballooned cannula |
US4704102A (en) * | 1982-09-30 | 1987-11-03 | Geneco Inc. | Method of eliminating intra abdominal infections |
US4512762A (en) * | 1982-11-23 | 1985-04-23 | The Beth Israel Hospital Association | Method of treatment of atherosclerosis and a balloon catheter for same |
US4531935A (en) * | 1983-01-13 | 1985-07-30 | Med-West, Incorporated | Cardioplegia/air aspiration cannula |
US4540399A (en) * | 1983-02-01 | 1985-09-10 | Ken Litzie | Emergency bypass system |
US4681117A (en) * | 1983-02-15 | 1987-07-21 | Brodman Richard F | Intracardiac catheter and a method for detecting myocardial ischemia |
US4767409A (en) * | 1983-05-23 | 1988-08-30 | Edward Weck Incorporated | Catheter protective shield |
US4596552A (en) * | 1983-06-10 | 1986-06-24 | Dlp Inc. | Cardioplegia cannula |
US4552558A (en) * | 1983-07-14 | 1985-11-12 | Rudolph Muto | Pressure warning, indicating and applying monitor for cuff type indwelling devices |
DE3325797A1 (en) * | 1983-07-16 | 1985-01-31 | Natec Inst Naturwiss | Balloon-tipped catheter, especially an endotracheal catheter |
US4714460A (en) * | 1983-07-29 | 1987-12-22 | Reynaldo Calderon | Methods and systems for retrograde perfusion in the body for curing it of the disease or immume deficiency |
US4585000A (en) | 1983-09-28 | 1986-04-29 | Cordis Corporation | Expandable device for treating intravascular stenosis |
US5275622A (en) | 1983-12-09 | 1994-01-04 | Harrison Medical Technologies, Inc. | Endovascular grafting apparatus, system and method and devices for use therewith |
US4787899A (en) * | 1983-12-09 | 1988-11-29 | Lazarus Harrison M | Intraluminal graft device, system and method |
US4631052A (en) * | 1984-01-03 | 1986-12-23 | Intravascular Surgical Instruments, Inc. | Method and apparatus for surgically removing remote deposits |
US5033998A (en) | 1984-01-20 | 1991-07-23 | Eliot Corday | Retrograde delivery of pharmacologic and diagnostic agents via venous circulation |
US4689041A (en) * | 1984-01-20 | 1987-08-25 | Eliot Corday | Retrograde delivery of pharmacologic and diagnostic agents via venous circulation |
EP0335205A1 (en) | 1984-01-20 | 1989-10-04 | Corday, Eliot, Dr. | Catheter for retroinfusion of pharmalogical agents |
US4902273A (en) | 1984-02-21 | 1990-02-20 | Choy Daniel S J | Heart assist device |
US4934996A (en) | 1984-02-27 | 1990-06-19 | Boston Scientific Corporation | Pressure-controlled intermittent coronary sinus occlusion apparatus and method |
US4969470A (en) | 1984-02-27 | 1990-11-13 | Boston Scientific Corporation | Heart analysis using pressure-controlled intermittent coronary sinus occlusion |
US4627436A (en) | 1984-03-01 | 1986-12-09 | Innoventions Biomedical Inc. | Angioplasty catheter and method for use thereof |
US4548597A (en) | 1984-03-19 | 1985-10-22 | Minnesota Mining And Manufacturing Company | Dual catheter and method for separately withdrawing fluids from the human heart |
US4592340A (en) * | 1984-05-02 | 1986-06-03 | Boyles Paul W | Artificial catheter means |
US4705507A (en) * | 1984-05-02 | 1987-11-10 | Boyles Paul W | Arterial catheter means |
US4664125A (en) * | 1984-05-10 | 1987-05-12 | Pinto John G | Flow-occluding method for the diagnosis of heart conditions |
US4883458A (en) | 1987-02-24 | 1989-11-28 | Surgical Systems & Instruments, Inc. | Atherectomy system and method of using the same |
US4979939A (en) | 1984-05-14 | 1990-12-25 | Surgical Systems & Instruments, Inc. | Atherectomy system with a guide wire |
US5007896A (en) | 1988-12-19 | 1991-04-16 | Surgical Systems & Instruments, Inc. | Rotary-catheter for atherectomy |
US4610661A (en) * | 1984-06-13 | 1986-09-09 | Possis Medical, Incorporated | Perfusion device |
DE3426300A1 (en) * | 1984-07-17 | 1986-01-30 | Doguhan Dr.med. 6000 Frankfurt Baykut | TWO-WAY VALVE AND ITS USE AS A HEART VALVE PROSTHESIS |
USRE33258E (en) | 1984-07-23 | 1990-07-10 | Surgical Dynamics Inc. | Irrigating, cutting and aspirating system for percutaneous surgery |
US4580568A (en) * | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
US4648384A (en) * | 1984-11-21 | 1987-03-10 | Schmukler Robert E | Retrograde coronary sinus perfusion device and method |
SU1271508A1 (en) | 1984-11-29 | 1986-11-23 | Горьковский государственный медицинский институт им.С.М.Кирова | Artificial heart valve |
US4798588A (en) * | 1984-12-03 | 1989-01-17 | Rene Aillon | Central venous pressure catheter and method for using |
US4601706A (en) * | 1984-12-03 | 1986-07-22 | Rene Aillon | Central venous pressure catheter for preventing air embolism and method of making |
US4722347A (en) * | 1985-01-15 | 1988-02-02 | Applied Biometrics, Inc. | Apparatus for measuring cardiac output |
US4770652A (en) * | 1985-02-12 | 1988-09-13 | Mahurkar Sakharam D | Method and apparatus for using dual-lumen catheters for extracorporeal treatment |
FR2577424B1 (en) | 1985-02-20 | 1989-04-28 | Gilles Karcher | CORONARY PERFUSION PUMP |
FR2577423B1 (en) * | 1985-02-20 | 1989-05-05 | Gilles Karcher | CIRCULATORY AND CORONARY ASSISTANCE PUMP WITH INTRA-AORTIC BALLOONS |
US4741328A (en) * | 1985-03-14 | 1988-05-03 | Shlomo Gabbay | Means for intraaortic assist and method of positioning a catheter therefor |
US4639252A (en) * | 1985-04-05 | 1987-01-27 | Research Medical, Inc. | Venous return catheter |
US4601713A (en) * | 1985-06-11 | 1986-07-22 | Genus Catheter Technologies, Inc. | Variable diameter catheter |
US4785795A (en) * | 1985-07-15 | 1988-11-22 | Abiomed Cardiovascular, Inc. | High-frequency intra-arterial cardiac support system |
NL8502382A (en) | 1985-08-30 | 1987-03-16 | Martinus Jacobus Antonius Joha | CATHETER SUITABLE FOR MULTIPLE PURPOSES. |
NL8600338A (en) | 1986-02-11 | 1987-09-01 | Louis Johannes Karel Jozef Rey | CATHETER PROVIDED WITH POSITIONERS. |
SU1371701A1 (en) | 1986-03-11 | 1988-02-07 | Военно-Медицинская Краснознаменная Академия Им.С.М.Кирова | Artificial valve of heart |
US4809681A (en) | 1986-03-28 | 1989-03-07 | Aisin Seiki Kabushiki Kaisha | Electrocardiographic measurement method for controlling an intra-aortic balloon pump |
US4692148A (en) * | 1986-03-28 | 1987-09-08 | Aisin Seiki Kabushiki Kaisha | Intra-aortic balloon pump apparatus and method of using same |
US4721109A (en) * | 1986-04-08 | 1988-01-26 | Healey Maureen A | Temporary anastomotic device |
IL78755A0 (en) * | 1986-05-12 | 1986-08-31 | Biodan Medical Systems Ltd | Applicator for insertion into a body opening for medical purposes |
IT8629545V0 (en) | 1986-06-12 | 1986-06-12 | Fina Ernesto | SET BALLOON URETERAL CATHETER BALLOON FOR EXTRACTION OF URETERAL STONES |
EP0249338A3 (en) | 1986-06-12 | 1988-12-14 | C.R. Bard, Inc. | Retroperfusion catheter |
US4753637A (en) * | 1986-07-16 | 1988-06-28 | The John Hopkins University | Catheter having means for controlling the insertion depth |
US4723936A (en) * | 1986-07-22 | 1988-02-09 | Versaflex Delivery Systems Inc. | Steerable catheter |
US4790825A (en) * | 1986-09-05 | 1988-12-13 | Electro Catheter Corporation | Closed chest cannulation method and device for atrial-major artery bypass |
US4777951A (en) * | 1986-09-19 | 1988-10-18 | Mansfield Scientific, Inc. | Procedure and catheter instrument for treating patients for aortic stenosis |
US4722732A (en) * | 1986-10-20 | 1988-02-02 | James Martin | Intravenous fluid supply system |
US4723550A (en) * | 1986-11-10 | 1988-02-09 | Cordis Corporation | Leakproof hemostasis valve with single valve member |
US4821722A (en) | 1987-01-06 | 1989-04-18 | Advanced Cardiovascular Systems, Inc. | Self-venting balloon dilatation catheter and method |
US4771777A (en) * | 1987-01-06 | 1988-09-20 | Advanced Cardiovascular Systems, Inc. | Perfusion type balloon dilatation catheter, apparatus and method |
US5024668A (en) | 1987-01-20 | 1991-06-18 | Rocky Mountain Research, Inc. | Retrograde perfusion system, components and method |
US4804365A (en) | 1987-02-13 | 1989-02-14 | C. R. Bard | Vascular cannulae for transfemoral cardiopulmonary bypass and method of use |
US5250069A (en) | 1987-02-27 | 1993-10-05 | Terumo Kabushiki Kaisha | Catheter equipped with expansible member and production method thereof |
US4878495A (en) | 1987-05-15 | 1989-11-07 | Joseph Grayzel | Valvuloplasty device with satellite expansion means |
US5011468A (en) | 1987-05-29 | 1991-04-30 | Retroperfusion Systems, Inc. | Retroperfusion and retroinfusion control apparatus, system and method |
US4865581A (en) | 1987-05-29 | 1989-09-12 | Retroperfusion Systems, Inc. | Retroperfusion control apparatus, system and method |
US5059167A (en) | 1987-05-29 | 1991-10-22 | Retroperfusion Systems, Inc. | Retroperfusion and retroinfusion control apparatus, system and method |
US4796629A (en) * | 1987-06-03 | 1989-01-10 | Joseph Grayzel | Stiffened dilation balloon catheter device |
US4794928A (en) * | 1987-06-10 | 1989-01-03 | Kletschka Harold D | Angioplasty device and method of using the same |
US4902272A (en) | 1987-06-17 | 1990-02-20 | Abiomed Cardiovascular, Inc. | Intra-arterial cardiac support system |
JPS6415056A (en) | 1987-07-09 | 1989-01-19 | Hanarou Maeda | Body indwelling tube |
US4808165A (en) | 1987-09-03 | 1989-02-28 | Carr Ann M | Inflation/deflation device for balloon catheter |
US4850969A (en) | 1987-10-01 | 1989-07-25 | Retroperfusion Systems, Inc. | Retroperfusion catheter and tip construction for use therewith |
US4848344A (en) | 1987-11-13 | 1989-07-18 | Cook, Inc. | Balloon guide |
US4811737A (en) | 1987-11-16 | 1989-03-14 | Schneider-Shiley (Usa) Inc. | Self-purging balloon catheter |
JPH01145074A (en) | 1987-12-01 | 1989-06-07 | Terumo Corp | Balloon catheter |
DE3785213T2 (en) | 1987-12-21 | 1993-08-26 | Reynaldo Calderon | DEVICE FOR RETROPERFUSING THE BODY FOR THE PURPOSE OF HEALING A DISEASE OR IMMUNEWAY. |
GB8800447D0 (en) | 1988-01-09 | 1988-02-10 | Smiths Industries Plc | Inflation indicators for cuffed tubes |
US4886507A (en) | 1988-02-01 | 1989-12-12 | Medex, Inc. | Y connector for angioplasty procedure |
US4917667A (en) | 1988-02-11 | 1990-04-17 | Retroperfusion Systems, Inc. | Retroperfusion balloon catheter and method |
US4960412A (en) | 1988-04-15 | 1990-10-02 | Universal Medical Instrument Corp. | Catheter introducing system |
US5226427A (en) | 1988-04-28 | 1993-07-13 | Research Medical Inc. | Removable stylet for retrograde cardioplegia catheter and methods for use |
US5021045A (en) | 1988-04-28 | 1991-06-04 | Research Medical, Inc. | Retrograde venous cardioplegia catheters and methods of use and manufacture |
US4889137A (en) | 1988-05-05 | 1989-12-26 | The United States Of America As Reprsented By The Department Of Health And Human Services | Method for improved use of heart/lung machine |
US5069661A (en) | 1988-05-18 | 1991-12-03 | Brigham And Women's Hospital | Circulatory support system |
US6120437A (en) * | 1988-07-22 | 2000-09-19 | Inbae Yoon | Methods for creating spaces at obstructed sites endoscopically and methods therefor |
US4877031A (en) | 1988-07-22 | 1989-10-31 | Advanced Cardiovascular Systems, Inc. | Steerable perfusion dilatation catheter |
US5011469A (en) | 1988-08-29 | 1991-04-30 | Shiley, Inc. | Peripheral cardiopulmonary bypass and coronary reperfusion system |
US5073168A (en) | 1988-10-05 | 1991-12-17 | Danforth John W | Y-adaptor and percutaneous sheath for intravascular catheters |
US4943275A (en) | 1988-10-14 | 1990-07-24 | Abiomed Limited Partnership | Insertable balloon with curved support |
US4877035A (en) | 1988-10-12 | 1989-10-31 | Trustees Of The University Of Pennsylvania | Measurement of the end-systolic pressure-volume relation using intraaortic balloon occlusion |
US5069662A (en) | 1988-10-21 | 1991-12-03 | Delcath Systems, Inc. | Cancer treatment |
US5011488A (en) | 1988-12-07 | 1991-04-30 | Robert Ginsburg | Thrombus extraction system |
US4927412A (en) | 1988-12-08 | 1990-05-22 | Retroperfusion Systems, Inc. | Coronary sinus catheter |
US4966604A (en) | 1989-01-23 | 1990-10-30 | Interventional Technologies Inc. | Expandable atherectomy cutter with flexibly bowed blades |
US5021044A (en) | 1989-01-30 | 1991-06-04 | Advanced Cardiovascular Systems, Inc. | Catheter for even distribution of therapeutic fluids |
US4943277A (en) | 1989-03-24 | 1990-07-24 | Bolling Steven F | Retrograde coronary sinus cardioplegia cannula and method for using same in heart surgery |
US5176619A (en) | 1989-05-05 | 1993-01-05 | Jacob Segalowitz | Heart-assist balloon pump with segmented ventricular balloon |
US5041098A (en) | 1989-05-19 | 1991-08-20 | Strato Medical Corporation | Vascular access system for extracorporeal treatment of blood |
US4994033A (en) | 1989-05-25 | 1991-02-19 | Schneider (Usa) Inc. | Intravascular drug delivery dilatation catheter |
US5045072A (en) | 1989-06-13 | 1991-09-03 | Cordis Corporation | Catheter having highly radiopaque, flexible tip |
HU212760B (en) | 1989-06-20 | 1997-02-28 | Denes | Method and device for the apportion of chemical materials into the vein wall |
US4985014A (en) | 1989-07-11 | 1991-01-15 | Orejola Wilmo C | Ventricular venting loop |
US5047041A (en) | 1989-08-22 | 1991-09-10 | Samuels Peter B | Surgical apparatus for the excision of vein valves in situ |
DE69011784D1 (en) | 1989-08-25 | 1994-09-29 | Bard Inc C R | Pleated balloon dilatation catheter and method of manufacture. |
US5013296A (en) | 1989-09-21 | 1991-05-07 | Research Medical, Inc. | Antegrade cardioplegia cannula |
US4986830A (en) | 1989-09-22 | 1991-01-22 | Schneider (U.S.A.) Inc. | Valvuloplasty catheter with balloon which remains stable during inflation |
US5109859A (en) | 1989-10-04 | 1992-05-05 | Beth Israel Hospital Association | Ultrasound guided laser angioplasty |
US5089015A (en) | 1989-11-28 | 1992-02-18 | Promedica International | Method for implanting unstented xenografts and allografts |
US5009636A (en) | 1989-12-06 | 1991-04-23 | The Kendall Company | Dual-lumen catheter apparatus and method |
JP2528011B2 (en) | 1989-12-20 | 1996-08-28 | テルモ株式会社 | Catheter |
US5049132A (en) | 1990-01-08 | 1991-09-17 | Cordis Corporation | Balloon catheter for delivering therapeutic agents |
US5405320A (en) | 1990-01-08 | 1995-04-11 | The Curators Of The University Of Missouri | Multiple lumen catheter for hemodialysis |
US5374245A (en) | 1990-01-10 | 1994-12-20 | Mahurkar; Sakharam D. | Reinforced multiple-lumen catheter and apparatus and method for making the same |
US5090960A (en) | 1990-01-12 | 1992-02-25 | Don Michael T Anthony | Regional perfusion dissolution catheter |
US5163905A (en) * | 1990-01-12 | 1992-11-17 | Don Michael T Anthony | Regional perfusion dissolution catheter |
US5041093A (en) | 1990-01-31 | 1991-08-20 | Boston Scientific Corp. | Catheter with foraminous anchor |
US5116305A (en) | 1990-02-01 | 1992-05-26 | Abiomed, Inc. | Curved intra aortic balloon with non-folding inflated balloon membrane |
US5197971A (en) | 1990-03-02 | 1993-03-30 | Bonutti Peter M | Arthroscopic retractor and method of using the same |
US4990143A (en) | 1990-04-09 | 1991-02-05 | Sheridan Catheter Corporation | Reinforced medico-surgical tubes |
US5106368A (en) | 1990-04-20 | 1992-04-21 | Cook Incorporated | Collapsible lumen catheter for extracorporeal treatment |
US5236413B1 (en) | 1990-05-07 | 1996-06-18 | Andrew J Feiring | Method and apparatus for inducing the permeation of medication into internal tissue |
US5411552A (en) | 1990-05-18 | 1995-05-02 | Andersen; Henning R. | Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis |
US5197952A (en) | 1990-06-13 | 1993-03-30 | Dlp, Inc. | Auto-inflating catheter cuff |
US5395330A (en) | 1990-06-13 | 1995-03-07 | Dlp, Inc. | Auto-inflating catheter cuff |
US5270005A (en) | 1990-09-07 | 1993-12-14 | Baxter International Inc. | Extracorporeal blood oxygenation system incorporating integrated reservoir-membrane oxygenerator-heat exchanger and pump assembly |
JP2830440B2 (en) | 1990-09-21 | 1998-12-02 | 東洋紡績株式会社 | Cannula |
US5088984A (en) | 1990-10-03 | 1992-02-18 | Tri-State Hospital Supply Corporation | Medical connector |
US5527292A (en) | 1990-10-29 | 1996-06-18 | Scimed Life Systems, Inc. | Intravascular device for coronary heart treatment |
US5186713A (en) | 1990-11-01 | 1993-02-16 | Baxter International Inc. | Extracorporeal blood oxygenation system and method for providing hemoperfusion during transluminal balloon angioplasty procedures |
US5053008A (en) | 1990-11-21 | 1991-10-01 | Sandeep Bajaj | Intracardiac catheter |
US5308320A (en) | 1990-12-28 | 1994-05-03 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon catheter and associated method |
US5152771A (en) | 1990-12-31 | 1992-10-06 | The Board Of Supervisors Of Louisiana State University | Valve cutter for arterial by-pass surgery |
US5181518A (en) | 1991-02-04 | 1993-01-26 | Mcdonagh Paul F | Method of evaluating cardioprotective agents |
AR245376A1 (en) | 1991-02-25 | 1994-01-31 | Liliana Rosa Grinfeld Y Robert | Arterial profusion nozzle, for extra-corporal circulation and other uses. |
US5188630A (en) * | 1991-03-25 | 1993-02-23 | Christoudias George C | Christoudias endospongestick probe |
US5219326A (en) | 1991-03-27 | 1993-06-15 | Hattler Brack G | Inflatable percutaneous oxygenator |
US5295958A (en) | 1991-04-04 | 1994-03-22 | Shturman Cardiology Systems, Inc. | Method and apparatus for in vivo heart valve decalcification |
US5217466A (en) * | 1991-04-19 | 1993-06-08 | Hasson Harrith M | Guide for facilitating the performance of internal surgery |
US5167628A (en) | 1991-05-02 | 1992-12-01 | Boyles Paul W | Aortic balloon catheter assembly for indirect infusion of the coronary arteries |
US5322500A (en) | 1991-05-09 | 1994-06-21 | Cardio Pulmonary Supplies, Inc. | Variable ratio blood-additive solution device and delivery system |
US5112347A (en) | 1991-05-14 | 1992-05-12 | Taheri Syde A | Embolectomy catheter, and method of operating same |
US5558644A (en) * | 1991-07-16 | 1996-09-24 | Heartport, Inc. | Retrograde delivery catheter and method for inducing cardioplegic arrest |
US5584803A (en) | 1991-07-16 | 1996-12-17 | Heartport, Inc. | System for cardiac procedures |
US5370685A (en) * | 1991-07-16 | 1994-12-06 | Stanford Surgical Technologies, Inc. | Endovascular aortic valve replacement |
US5735290A (en) * | 1993-02-22 | 1998-04-07 | Heartport, Inc. | Methods and systems for performing thoracoscopic coronary bypass and other procedures |
US5458574A (en) | 1994-03-16 | 1995-10-17 | Heartport, Inc. | System for performing a cardiac procedure |
US5766151A (en) * | 1991-07-16 | 1998-06-16 | Heartport, Inc. | Endovascular system for arresting the heart |
US5433700A (en) | 1992-12-03 | 1995-07-18 | Stanford Surgical Technologies, Inc. | Method for intraluminally inducing cardioplegic arrest and catheter for use therein |
US5125903A (en) | 1991-08-01 | 1992-06-30 | Medtronic, Inc. | Hemostasis valve |
US5195942A (en) | 1991-08-12 | 1993-03-23 | Institute Of Critical Care Medicine | Cardiac arrest treatment |
US5259839A (en) | 1991-08-23 | 1993-11-09 | Scimed Life Systems, Inc. | Balloon catheter with guidewire valve |
US5334142A (en) | 1991-09-09 | 1994-08-02 | New York University | Selective aortic perfusion system |
US5216032A (en) | 1991-09-30 | 1993-06-01 | The University Of North Carolina At Chapel Hill | Selective aortic arch perfusion using perfluorochemical and alpha adrenergic agonist to treat cardiac arrest |
US5439443A (en) | 1991-09-30 | 1995-08-08 | Nippon Zeon Co., Ltd. | Balloon catheter |
JP2979804B2 (en) | 1991-12-13 | 1999-11-15 | 株式会社ニッショー | Aortic occlusion balloon catheter |
US5330498A (en) | 1991-12-17 | 1994-07-19 | Hill John D | Blood vessel occlusion trocar |
US5254097A (en) | 1992-01-06 | 1993-10-19 | Datascope Investment Corp. | Combined percutaneous cardiopulmonary bypass (PBY) and intra-aortic balloon (IAB) access cannula |
US5246007A (en) | 1992-03-13 | 1993-09-21 | Cardiometrics, Inc. | Vascular catheter for measuring flow characteristics and method |
US5295960A (en) * | 1992-04-01 | 1994-03-22 | Applied Medical Resources Corporation | Catheter with interior balloon |
US5254089A (en) | 1992-04-02 | 1993-10-19 | Boston Scientific Corp. | Medication dispensing balloon catheter |
WO1993020861A1 (en) * | 1992-04-17 | 1993-10-28 | Yoshiharu Kiyota | Intracorporeal heart assisting device |
US5382239A (en) | 1992-04-24 | 1995-01-17 | Becton, Dickinson And Company | Repositional catheter fixation device |
US5395331A (en) | 1992-04-27 | 1995-03-07 | Minnesota Mining And Manufacturing Company | Retrograde coronary sinus catheter having a ribbed balloon |
US5324260A (en) | 1992-04-27 | 1994-06-28 | Minnesota Mining And Manufacturing Company | Retrograde coronary sinus catheter |
US5401241A (en) * | 1992-05-07 | 1995-03-28 | Inamed Development Co. | Duodenal intubation catheter |
SE514860C2 (en) | 1992-07-03 | 2001-05-07 | Lars Wiklund | Apparatus and method for treating circulatory arrest |
NL9201222A (en) | 1992-07-08 | 1994-02-01 | Marinus Adrianus Josephus Mari | RETURN CANULE. |
US5525388A (en) | 1992-08-07 | 1996-06-11 | Advanced Cardiovascular Systems, Inc. | Dilatation balloon with constant wall thickness |
US5702365A (en) | 1992-09-08 | 1997-12-30 | King; Toby St. John | Daul-lumen catheter |
JP3598306B2 (en) | 1992-09-21 | 2004-12-08 | キューエルティ インク. | Bioactivation of photosensitizers in blood through skin |
US5250038A (en) | 1992-10-09 | 1993-10-05 | Cook Incorporated | Multiple lumen vascular access introducer sheath |
US5364347A (en) * | 1992-11-13 | 1994-11-15 | Cardiovascular Imaging Systems, Inc. | Catheter system having a balloon angioplasty device disposed over a work element lumen and method of use |
US5370618A (en) | 1992-11-20 | 1994-12-06 | World Medical Manufacturing Corporation | Pulmonary artery polyurethane balloon catheter |
US5330451A (en) | 1992-12-17 | 1994-07-19 | Shelhigh, Inc. | Multi purpose perfusion cannula |
US5487730A (en) | 1992-12-30 | 1996-01-30 | Medtronic, Inc. | Balloon catheter with balloon surface retention means |
US5322509A (en) | 1993-01-06 | 1994-06-21 | Iowa Methodist Medical Center | Cardiac catheter |
US5728151A (en) * | 1993-02-22 | 1998-03-17 | Heartport, Inc. | Intercostal access devices for less-invasive cardiovascular surgery |
US5383856A (en) | 1993-03-19 | 1995-01-24 | Bersin; Robert M. | Helical spiral balloon catheter |
US5409460A (en) | 1993-04-15 | 1995-04-25 | The Beta Group Inc. | Intra-luminal expander assembly |
US5385548A (en) | 1993-04-22 | 1995-01-31 | Dlp, Inc. | Balloon catheter for retrograde perfusion |
US5456667A (en) | 1993-05-20 | 1995-10-10 | Advanced Cardiovascular Systems, Inc. | Temporary stenting catheter with one-piece expandable segment |
US5428070A (en) | 1993-06-11 | 1995-06-27 | The Board Of Trustees Of The Leland Stanford Junior University | Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity |
US5370640A (en) | 1993-07-01 | 1994-12-06 | Kolff; Jack | Intracorporeal catheter placement apparatus and method |
US5421825A (en) | 1993-10-06 | 1995-06-06 | Farcot; Jean-Christian | Percutaneous vascular introduction device for the feeding of an extracorporeal blood circuit |
US5505698A (en) | 1993-10-29 | 1996-04-09 | Medtronic, Inc. | Cardioplegia catheter with elongated cuff |
US5613948A (en) * | 1993-11-12 | 1997-03-25 | Cordis Corporation | Annular perfusion balloon catheter |
US5591129A (en) | 1994-03-02 | 1997-01-07 | Scimed Life Systems, Inc. | Perfusion balloon angioplasty catheter |
US5456665C1 (en) | 1994-03-04 | 2001-05-22 | Arrow Internat Invest Corp | Intra-aortic balloon catheter |
US5595181A (en) | 1994-03-24 | 1997-01-21 | Hubbard; A. Robert | System for providing cardiac output and shunt quantitation |
US5437633A (en) | 1994-03-30 | 1995-08-01 | The University Of North Carolina At Chapel Hill | Selective aortic arch perfusion |
US5451207A (en) | 1994-04-25 | 1995-09-19 | The Regents Of The University Of California | Method of coronary plaque removal with bypass and perfusion |
US5597377A (en) | 1994-05-06 | 1997-01-28 | Trustees Of Boston University | Coronary sinus reperfusion catheter |
US5478309A (en) | 1994-05-27 | 1995-12-26 | William P. Sweezer, Jr. | Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery |
US5725552A (en) | 1994-07-08 | 1998-03-10 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
IT1272801B (en) * | 1994-09-02 | 1997-06-30 | Mauro Dimitri | SPECIFIC CATHETER FOR PERCUTANEOUS GASTROSTOMY |
NL9401951A (en) | 1994-11-22 | 1996-07-01 | Cordis Europ | Balloon catheter. |
US5527282A (en) * | 1994-12-09 | 1996-06-18 | Segal; Jerome | Vascular dilatation device and method |
DE69632776T2 (en) | 1995-03-30 | 2005-08-25 | Heartport, Inc., Redwood City | SYSTEM FOR IMPLEMENTING ENDOVASCULAR INTERVENTION |
CA2218105A1 (en) * | 1995-03-30 | 1996-10-03 | Heartport, Inc. | Endovascular cardiac venting catheter and method |
US5578010A (en) | 1995-03-31 | 1996-11-26 | Applied Medical Resources Corporation | Multiple lumen catheter and method of construction |
NL1000413C2 (en) * | 1995-05-22 | 1996-11-25 | Cordis Europ | Balloon catheter with balloon protection jacket. |
US5863366A (en) | 1995-06-07 | 1999-01-26 | Heartport, Inc. | Method of manufacture of a cannula for a medical device |
WO1996040342A1 (en) * | 1995-06-07 | 1996-12-19 | Cardima, Inc. | Guiding catheter for coronary sinus |
US5980503A (en) * | 1996-04-08 | 1999-11-09 | Guidant Corporation | Endoscopic cardioplegia infusion cannula and method of use |
WO1997042879A1 (en) * | 1996-05-14 | 1997-11-20 | Embol-X, Inc. | Aortic occluder with associated filter and methods of use during cardiac surgery |
US6217548B1 (en) * | 1996-05-14 | 2001-04-17 | Embol-X, Inc. | Cardioplegia balloon cannula |
US5827237A (en) | 1996-06-17 | 1998-10-27 | Cardeon Corporation | Dual lumen catheter with controlled antegrade and retrograde fluid flow |
JP2001503286A (en) | 1996-06-17 | 2001-03-13 | カーデオン コーポレイション | Externally valved catheter for controlled antegrade and retrograde fluid flow |
US5749852A (en) | 1996-07-23 | 1998-05-12 | Medtronic, Inc. | Sheath system for autoperfusion dilatation catheter balloon |
US5868708A (en) * | 1997-05-07 | 1999-02-09 | Applied Medical Resources Corporation | Balloon catheter apparatus and method |
US6258120B1 (en) * | 1997-12-23 | 2001-07-10 | Embol-X, Inc. | Implantable cerebral protection device and methods of use |
US5928260A (en) * | 1997-07-10 | 1999-07-27 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
US5928192A (en) * | 1997-07-24 | 1999-07-27 | Embol-X, Inc. | Arterial aspiration |
US6099506A (en) * | 1997-09-26 | 2000-08-08 | Macoviak; John A. | Introducer and perfusion cannula |
US6159178A (en) * | 1998-01-23 | 2000-12-12 | Heartport, Inc. | Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested |
US6210365B1 (en) * | 1998-08-14 | 2001-04-03 | Cardiovention, Inc. | Perfusion catheter system having sutureless arteriotomy seal and methods of use |
US6048332A (en) | 1998-10-09 | 2000-04-11 | Ave Connaught | Dimpled porous infusion balloon |
-
1998
- 1998-01-23 US US09/012,833 patent/US6159178A/en not_active Expired - Fee Related
- 1998-07-09 US US09/112,514 patent/US6350252B2/en not_active Expired - Lifetime
-
1999
- 1999-01-21 US US09/235,043 patent/US6592547B2/en not_active Expired - Lifetime
- 1999-01-22 AU AU23345/99A patent/AU752773B2/en not_active Expired
- 1999-01-22 ES ES99903285T patent/ES2241259T3/en not_active Expired - Lifetime
- 1999-01-22 EP EP04001542A patent/EP1413326A3/en not_active Withdrawn
- 1999-01-22 WO PCT/US1999/001340 patent/WO1999037202A2/en active IP Right Grant
- 1999-01-22 AT AT99903285T patent/ATE290814T1/en not_active IP Right Cessation
- 1999-01-22 DE DE69924198T patent/DE69924198T2/en not_active Expired - Lifetime
- 1999-01-22 CA CA002284752A patent/CA2284752A1/en not_active Abandoned
- 1999-01-22 EP EP99903285A patent/EP0983015B1/en not_active Expired - Lifetime
-
2000
- 2000-10-10 US US09/685,383 patent/US6589206B1/en not_active Expired - Lifetime
-
2001
- 2001-08-28 US US09/940,817 patent/US20020072708A1/en not_active Abandoned
-
2002
- 2002-05-16 US US10/147,247 patent/US20020128597A1/en not_active Abandoned
- 2002-06-05 US US10/162,799 patent/US6902556B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1999037202A3 (en) | 1999-12-23 |
US20010056260A1 (en) | 2001-12-27 |
US20020128597A1 (en) | 2002-09-12 |
AU752773B2 (en) | 2002-09-26 |
DE69924198T2 (en) | 2006-01-26 |
US20020072708A1 (en) | 2002-06-13 |
US20010041858A1 (en) | 2001-11-15 |
ATE290814T1 (en) | 2005-04-15 |
EP0983015B1 (en) | 2005-03-16 |
US6902556B2 (en) | 2005-06-07 |
EP1413326A3 (en) | 2004-05-06 |
AU2334599A (en) | 1999-08-09 |
US6350252B2 (en) | 2002-02-26 |
US6589206B1 (en) | 2003-07-08 |
ES2241259T3 (en) | 2005-10-16 |
US20020151870A1 (en) | 2002-10-17 |
WO1999037202A2 (en) | 1999-07-29 |
EP1413326A2 (en) | 2004-04-28 |
US6159178A (en) | 2000-12-12 |
EP0983015A2 (en) | 2000-03-08 |
DE69924198D1 (en) | 2005-04-21 |
US6592547B2 (en) | 2003-07-15 |
EP0983015A4 (en) | 2000-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0983015B1 (en) | Arterial cannula with an introducer having a cutting element | |
US6176851B1 (en) | Cardioplegia occluder | |
US6217548B1 (en) | Cardioplegia balloon cannula | |
US6090096A (en) | Antegrade cardioplegia catheter and method | |
AU723379B2 (en) | Endovascular system for arresting the heart | |
US7695452B2 (en) | Method and apparatus for venous drainage and retrograde coronary perfusion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |